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There is increasing awareness for the potential effects of nutrition on mental health. Specifically, 
researchers are interested in the benefits of omega-3 polyunsaturated fatty acids (n-3 PUFA) and 
vitamin D on brain development and psychological well-being.  
The main objective of this thesis is to examine evidence for the relationship between nutritional 
intake, neurodevelopment, psychotic and depressive symptoms. This thesis consists of a series 
of studies designed to test several hypotheses. A review and meta-analysis tested the hypothesis 
that maternal fish oil intake/omega 3 supplementation during pregnancy is associated with better 
cognitive performance in offspring. Next, we used data from the Swedish Women's Lifestyle and 
Health Study, to test the hypothesis that low UV exposure is associated with more positive 
psychotic symptoms and with more severe depressive symptoms. For the purpose of this study 
we use UV exposure data as a primary index for vitamin D. Firstly, the results of meta-analysis 
showed that for the measure of overall cognitive ability the standardised difference in means 
(SMD) was estimated to 0.10 (95% CI, -0.01 to 0.20; p=0.07) and for memory functions the SMD 
was 0.21 (95% CI, 0.01 to 0.41; p=0.04). The observational studies showed better overall 
cognitive ability with pooled OR of 1.92 (95% CI, 1.61 to 2.30; p<0.001) and for the domain of 
language and verbal skills the OR was 1.93 (95% CI, 1.37 to 2.73; p<0.001) among children of 
mothers consuming 2 to 3 fish servings per week during pregnancy.  Maternal intake of fish oil 
during pregnancy is associated with improved cognitive abilities in the offspring. Secondly, the 
association between sun exposure and psychotic experiences was evaluated by quantile 
regression models. 34 279 women were included in the analysis. Women who reported no 
sunbathing holidays and two or more weeks of sunbathing holidays scored higher on the 
Community Assessment of Psychic Experience (CAPE) scale than women exposed to one week 
of sunbathing holidays across the entire distribution, when adjusting for age and education. 
Similarly, compared with women who reported a history of a single sunburn, the women with none 
or two or more sunburns showed higher scores on the CAPE scale with more women in the right 
part of the distribution. Thirdly, women who reported a history of two or more sunburns showed 
positive association with depressive symptoms, compared to history of a single sunburn, when 
adjusting for age and education. The findings suggest that in a population based cohort of middle 
aged women, both low and high sun exposure is associated with increased level of positive 
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Chapter 1 Introduction 
1.1 About schizophrenia and psychosis 
Approximately one in a hundred people will experience schizophrenia and might experience a 
collection of symptoms referred to as either positive or negative symptoms (Jablensky, 2000). 
According to the DSM-5 and ICD-10 (American Psychiatric Association, 2013; World Health 
Organization, 1992), the primary positive symptoms of psychosis are: hallucinations (auditory, 
visual, olfactory, and tactile), delusions (persecution, nihilism, grandiosity, control, thought 
possession, disorganised speech (stream of thought, flight of ideas, loosening of associations); 
disorders of behaviour (gross excitement/overactivity); motor abnormalities (catatonia, gross 
psychomotor retardation). Schizophrenia spectrum and other psychotic disorders include 
schizophrenia, other psychotic disorders, and schizotypal (personality) disorder. They are defined 
by abnormalities in one or more of the following five domains: delusions, hallucinations, 
disorganized thinking (speech), grossly disorganized or abnormal motor behaviour (including 
catatonia), and negative symptoms (American Psychiatric Association, 2013). 
Delusions are false beliefs that are firmly held on inadequate grounds; are not affected by rational 
argument or evidence to the contrary; furthermore it is not a conventional belief that the person 
might be expected to hold given her educational, cultural and religious background. Several types 
of delusions are recognised, either by the characteristics or the theme of the delusion. 
Hallucinations are perceptions experienced in the absence of an external stimulus to the 
corresponding sense organ. It differs from an illusion in being experienced as originating in the 
outside world (or sometimes within the person’s body) but not within the mind (e.g. mental 
imagery). A hallucination can be in the mind, with an illusion there is a stimulus which is 
misinterpreted. Disorganised speech is normally inferred by examining abnormalities in speech. 
Disorders of behaviour or motor abnormalities comprise a marked increase in the normal levels 
of activity, characterised by hyperactivity, or a marked decrease in activity, characterised by 
catatonia, or very slowed or fixed movements.  
Different disorders share common phenomenological features. This overlap in symptomology is 
perhaps most prominent in regards to symptoms of psychosis. For example, psychotic features 
such as positive (hallucinations, delusions), negative (apathy, avolition, and asociality), and 
disorganized (disorganized speech or behaviour) symptoms are the cornerstones of 
schizophrenia, however, they are also  observed across a broad spectrum of diagnoses outside 
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of the “psychotic disorders” category as defined by the current edition of the DSM. Consequently, 
an individual presenting with auditory hallucinations and delusional beliefs might be diagnosed 
with schizophrenia, schizoaffective disorder, bipolar disorder or major depressive disorder 




















1.1.1 Cognitive impairments and psychotic illnesses  
In chapter 3, I introduce the concept of cognitive functions related to omega 3 deficiency which 
are important to study due to cognitive impairments being documented as core features of 
schizophrenia and are related to functional status and other aspects of illness (Green, 1996, 
Heinrichs and Zakzanis, 1998). Further, lower cognitive ability in childhood is associated with 
increased risk of future schizophrenia (Aylward, Walker, & Bettes, 1984; Jones, Rodgers, Murray, 
& Marmot, 1994). Although they are common in schizophrenia, they are not specific to this illness. 
They are evident also in the subjects with affective disorders (Gilvarry et al., 2001, Goldberg et 
al., 1993, Gruzelier et al., 1988, McGrath et al., 1997, Sweeney et al., 2000, Zubieta et al., 2001) 
and other forms of functional psychosis (Mitrushina et al., 1996, Zanelli et al., 2010). However, it 
appears that neuropsychological impairments are more severe in schizophrenia. In several 
studies, patients with schizophrenia have been shown to be more impaired in a range of cognitive 
tests than patients with bipolar disorder and other functional psychotic conditions (Gilvarry et al., 
2001, Goldberg, 1999, Mitrushina et al., 1996, Seidman et al., 2002).  
Neuropsychological abnormalities are evident many years before the overt expression of any 
psychotic symptoms (Aylward et al., 1984, David et al., 1997, Davidson et al., 1999, Hoff et al., 
1999, Jones et al., 1994, Reichenberg et al., 2002). Dating back to the work of Spearman 
(Spearman, 1928), a distinction has been made between general and specific cognitive abilities. 
Two widely used indices of generalised neurocognitive performance have been applied in 
research: general measures of intelligence quotient (IQ), and composite scores or profiles derived 
from test batteries comprising multiple neuropsychological tests. Although both provide a 
measure of an individual’s overall cognitive functioning, the results of these assessments often 
do not overlap to a substantial degree. Neuropsychological test batteries typically focus on 
assessment of multiple cognitive abilities, such as memory, executive functions, and attention, 
and these include a strong component of novelty of testing requirements. IQ tests, on the other 
hand, have a lesser emphasis on specific abilities and novelty and greater emphasis on the 
assessment of crystallized abilities (Bratti and Bilder, 2006). 
1.1.2 Aetiology and treatment of schizophrenia 
As is the case with many mental disorders, the cause of schizophrenia is not known although 
both genetic and environmental factors have been implicated (Jim van Os & Kapur, 2009). There 
are a number of theories relating to neurotransmitter imbalances and functional magnetic 
resonance imaging (fMRI) studies have shown a broad array of brain abnormalities. The 
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conventional treatment for schizophrenia is usually long-term treatment with antipsychotic 
medication. A nutritional approach works alongside conventional treatment and there is 
preliminary evidence that omega-3 is an effective adjunct to antipsychotics (Emsley, Oosthuizen, 
& van Rensburg, 2003).   
The field of psychosis has long been aware that schizophrenia is more common in those born in 
winter and spring when sun exposure is minimum or none existing (Davies, Welham, Chant, 
Torrey, & McGrath, 2003). The prevalence of schizophrenia is associated with latitude – a finding 
first described by Fuller Torrey over 25 years ago (Torrey, 1977) and since replicated in 
systematic reviews (Davies et al., 2003). These findings have led to the hypothesis that low 
vitamin D (especially during early life) may be implicated in aetiology of schizophrenia (J. J. 
McGrath, Eyles, et al., 2010; J. J. McGrath, Burne, Féron, Mackay-Sim, & Eyles, 2010). The 
impact of vitamin D or sun exposure on brain changes in adult life has not been investigated.  
 
1.1.3 Psychotic experiences in the general population 
Recently it has been suggested that psychosis exists in the general population as a continuous 
phenotype rather than as an all-or-none occurrence (J van Os, Linscott, Myin-Germeys, 
Delespaul, & Krabbendam, 2009). Population-based studies have confirmed that psychotic 
experiences, for example, delusions and hallucinations, are indeed prevalent in the community 
(Johns et al., 2004; Kelleher & Cannon, 2011; Therman, Suvisaari, & Hultman, 2014). Early 
epidemiological studies included psychotic experiences in their research and focused on 
exploring potential risk indicators for later conversion to full psychosis (Kelleher & Cannon, 2011). 
This type of research has an interesting rationale as many of the risk factors associated with 
psychotic experiences in non-clinical population are also associated with schizophrenia and 
psychosis (J. J. McGrath et al., 2015) Further results from similar studies revealed that psychotic 
experiences are also related to the subsequent onset of a wide range of common mental 
disorders, including anxiety, depression, and substance use disorders (Saha et al., 2011; 
Varghese et al., 2011), Consequently, awareness is growing that the presence of psychotic 
symptoms may reflect a vulnerability to a wide range of adverse mental health outcomes (in 




1.2 Major Depressive Disorder  
According to the NICE guidelines, depression is defined as a broad and heterogeneous diagnostic 
grouping, central to which is depressed mood or loss of pleasure in most activities (NICE, 2009)  
Major depressive illness is common in the general population and it affects up to one sixth of the 
population, perhaps more (Doris, Ebmeier, & Shajahan, 1999). Reported by the WHO in 2015, 
globally, an estimated 350 million people of all ages suffer from depression. Depression is the 
primary cause of disability worldwide, and is a major contributor to the overall global burden of 
disease. Depression is more common in women than men (Bierut et al., 1999; Weissman & 
Olfson, 1995).  
DSM-5 criteria for depression list the key 2 symptoms:  
 Depressed mood most of the day, almost every day, indicated by your own subjective report 
or by the report of others. This mood might be characterized by sadness, emptiness, or 
hopelessness. 
 Markedly diminished interest or pleasure in all or almost all activities most of the day nearly 
every day and/or marked loss of interests or pleasure 
 (at least one of the above symptoms must occur most days, most of the time for at least 2 
weeks).  
As reported by Ingram, 2012, symptoms of depression may vary according to an individual's 
age and culture. Children who are depressed, for instance, may express symptoms of irritability 
rather than sadness or they may fail to make expected weight gains rather than lose weight. In 
contrast, older adults are more likely than younger adults to experience symptoms such as loss 
of appetite, loss of interest, and thoughts of death. Cultural differences also exist in the report of 
depressive symptoms (Ingram, 2012). For example, studies of American, Korean, Philippine, 
and Taiwanese college students found that Taiwanese students reported the lowest numbers of 
somatic symptoms and the highest numbers of affective symptoms (Kalibatseva, Leong, 
Kalibatseva, & Leong, 2011). Hence, one's age and culture seems to affect not whether 
depression is experienced, but rather how it is expressed (Ingram, 2012). 
Although the cause of depression is still unclear, it is becoming clear that a number of diverse 
factors are likely to be associated, both genetic and environmental (NICE, 2009). Several socio-
demographic correlates are found consistently across countries and cross-national data also 
document associations with numerous adverse outcomes, including difficulties in role transitions 
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(e.g., low education, high teen child-bearing, marital disruption, unstable employment), reduced 
role functioning (e.g., low marital quality, low work performance, low earnings), elevated risk of 
onset, persistence, and severity of a wide range of secondary disorders, and increased risk of 
early mortality due to physical disorders and suicide (Yirmiya, 2000). 
1.2.1 Depressive symptoms and its variations in the general population 
Data on prevalence of several symptoms of depression were consistently reported in general 
population samples. One study found that, of the nine symptoms assessed, the most frequently 
occurring were dysphoric mood (17.8%), increased sleep (15%), and loss of interest in other 
people or activities previously enjoyed (11.8%). The author of the paper concluded that the 
findings provided evidence that various symptoms of depression may be more common in the 
general population than previously suspected (Henderson & Pollard, 1992). Depressive 
symptoms have a high prevalence worldwide and have been associated with common physical 
and mental health problems (Bland, 1997; Phillips et al., 2009). Additionally, depressive 
symptoms have been considered as leading cause of mortality and morbidity, meaning they have 
become the most important public health concern (Ferrari et al., 2013).  
The seasonal variation of depressive symptoms has also received a considerable amount of 
attention in recent years. A specific form of seasonality, seasonal affective disorder (SAD) 
(Rosenthal, 1984) is known as winter depression. Magnusson concluded that in the general 
population, depressive symptoms peak in winter, and the most extreme form of this disposition, 
SAD, appears to be a relatively common in the general population (Magnusson, 2000). This 
overview of epidemiological studies on SAD reported the prevalence estimates of SAD across 20 
retrospective studies varied from 0% to 9.7%. SAD was more prevalent at higher northern 
latitudes, but the prevalence varied across ethnic groups (Magnusson, 2000). 
 
1.3 A link between nutrition and mental health   
The biological mechanisms underlying the aetiology of schizophrenia and psychotic symptoms 
and depression are mainly unknown. Genetic constitution is important, but environmental factors 
like an unhealthy lifestyle with a poor diet may be involved. Therefore it is important to understand 
an overall link between mental health and nutrition. Chapter 4 and 5 of the thesis include the 
examination of the link between psychotic and depressive symptoms in the general population to 
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vitamin D from the UV exposure. I also evaluated in my meta-analysis (chapter 3) the potential 
association between omega 3 deficiency in pregnant women and their children’s cognitive 
functions.  
The relationship between schizophrenia and nutrition is diverse and complex. Potential nutrient 
deficiencies are some of the most prominent concerns (Georgieff, 2007). Research indicates that 
individuals with schizophrenia tend to have diets that are higher in energy and fat, and lower in 
fruits and vegetables, vitamin D and omega 3 (Georgieff, 2007).  
Not much is understood about the connection between nutrition and depression while it is easily 
understood how a connection between nutritional deficiencies and physical illness could develop. 
For example, depression is typically thought of as strictly biochemical-based or emotionally-
rooted (Kohatsu, 2005). However, nutrition can play a key role in the onset as well as severity 
and duration of mental illness such as schizophrenia or depression (Payne, 2010). Many of the 
evident unhealthy food patterns that precede depression are the same as those that occur during 
depression. For instance, an increased risk of depression has been associated with higher intake 
of trans fatty acids (Sánchez-Villegas et al., 2011), fast food and commercial bakery (Martínez-
González & Sánchez-Villegas, 2015). 
.Nutritional neuroscience is an emerging discipline shedding light on the fact that nutritional 
factors are intertwined with human cognition, behaviour, and emotions. 
The dietary intake pattern of the general population in many European and American  countries 
reflects that they are often deficient in many nutrients, especially essential vitamins (i.e. vitamin 
D), minerals, and omega-3 fatty acids (Rao, Asha, Ramesh, & Rao, 2008). Additionally, low 
maternal fish consumption during pregnancy is reported to increase the risk for a low IQ and 
suboptimal neuro-developmental outcomes in childhood (Hibbeln et al., 2007), factors that in turn 
are associated with an increased risk for adult mental disorders like schizophrenia. The Finish 
study of adult’s prevalence of depressive symptoms and their relationship to fish consumptions 
showed that depressive symptoms in adults are common and the likelihood of having depressive 
symptoms was significantly higher among infrequent fish consumers than among frequent 
consumers (Tanskanen et al., 2001). Fatty fish is a rich dietary source of essential fatty acids and 
vitamin D, both of which could be implicated in the development of schizophrenia and depression 
throughout the lifespan. However, not much has been investigated on psychotic or depressive 




1.3.1 What are nutrients? 
Nutrients are chemical compounds needed for growth, repair, energy, and regulation of body 
functions. According to the British Nutrition Foundation, macronutrients (carbohydrate, protein 
and fat) are essential nutrients that provide energy for the body and are required in large amounts 
in the diet. They provide our bodies with energy and the building blocks for growth and 
maintenance of a healthy body. Micronutrients (vitamins, minerals and water) are essential for 
the proper functioning of every system in the body and are required in smaller amounts than 
macronutrients (http://www.nutrition.org.uk/ ). Figure 1 presents the primary essential nutrients in 




























Figure 2 Essential Human Nutrients 
 











1.3.2 Nutrients and the brain 
Nutrients play a critical role in cell proliferation, DNA synthesis, neurotransmitter and hormone 
metabolism, and are important components of enzyme systems (Zimmermann, 2011). Several 
studies suggest that nutrition has an important role for normal brain development prenatally, in 
childhood, as well as during adult life (Gómez-Pinilla, 2008). Nutrition is an important factor in 
brain development and deficiencies in several nutrients have been shown to have implications for 
brain and physical development.  The most well-known example is probably folate acid. Folate 
acid and choline have a role in the closure of the foetal neural tube, and prenatal folate deficiency 
has been associated with neural tube defects (NTD) (Shaw, Carmichael, Yang, Selvin, & Schaffer, 
2004). There is also evidence for association between folate intake before pregnancy and 
language development (Roth et al., 2012). These and other findings have led to worldwide 
fortification of foods with folate to prevent deficiency in pregnant women. Folate intake before 
pregnancy has recently been associated with lower risk for autism and language development 
(Roth et al., 2012).  
1.3.3 Vitamin D - more than just strong bones 
One of the nutrients discussed and examined in this thesis (chapter 3 and chapter 4) is vitamin D 
known as the sunshine vitamin. Although it’s called a vitamin, it is a fat-soluble vitamin that acts 
as a steroid hormone (Yetley et al., 2009). Hormones are compounds produced in one part of the 
body and transported to another part of the body where they apply a specific regulatory or 
functional effect. In this case, vitamin D the body makes vitamin D from cholesterol through a 
process triggered by the action of the sun’s ultraviolet B (UVB) rays on the skin (Calcium, Ross, 
Taylor, Yaktine, & Valle, 2011). Figure 1 presents the synthesis of vitamin D in humans. Sensible 
sun exposure can be an excellent source of vitamin D for both children and adults (Holick, 2004, 
2005). Vitamin D was originally known for its role in reducing the risk of rickets, but in the past 
three decades the benefits of vitamin D were extended to protection against many non-calcemic 
diseases (Grant, 2009; Harvey et al., 2009). .For example, decreased muscle function and 
increased fall risk in elderly people; prostate, breast and colorectal cancers; diabetes mellitus; 
and other health problems have been associated to low circulating levels of 25-hydroxyvitamin D 










Figure 3 Vitamin D Synthesis. 
 
Note 2 Adapted from Lau AH, How PP. The role of the pharmacist in the identification and management of 




There is increasing evidence for a link between vitamin D status and brain function (Deluca et al., 
2013). The first indirect evidence for vitamin D and its role in brain development and function was 
discovered and described by Stumpf et al (1982) who reported on vitamin D and its metabolites 
in the cerebrospinal fluid of healthy adults. The authors revealed that vitamin D receptors are 
widely spread in the embryonic brain prominently in the neuro-epithelium and proliferation zones 
(D. W. Eyles, Smith, Kinobe, Hewison, & McGrath, 2005; Stumpf, Sar, Clark, & DeLuca, 1982). 
The first real indications related to vitamin D and its role in brain function was provided by the 
presence of its receptor in the central nervous system (CNS). Later clues from animal studies (in 
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the neonatal and adult rats) added further weight to the hypothesis that vitamin D signalling is 
involved in brain function. These studies identified vitamin D receptors in several brain regions 
such as temporal, orbital and cingulate cortices, thalamus, accumbens, amygdala, olfactory 
system and pyramidal neurons of the hippocampus (Burkert, McGrath, & Eyles, 2003; Prüfer, 
Veenstra, Jirikowski, & Kumar, 1999; Veenstra et al., 1998). As for the human brain, later 
evidence for distribution of the vitamin D receptor was reported for the first time by Eyles et al 
providing clues the CNS’ ability to synthesise (1,25(OH)2D) the active form of vitamin D from 25 
hydroxyvitamin D (25(OH)D), which is the precursor inactive form, a  ‘storage’ form of vitamin D 
used to monitor serum levels (D. W. Eyles et al., 2005). This suggests that serum levels might 
influence the autocrine and paracrine production of 1,25(OH)2D, the active form of vitamin D, in 
the CNS , challenging the assumption that the brain is solely dependent on circulating 25(OH)D 
crossing the blood–brain barrier (D. W. Eyles et al., 2005; Hosseinpour & Wikvall, 2000). 
1.3.4 Omega 3 and brain functions  
Lately, there has been increased interest in the role of essential fatty acids (EFA) in 
neurodevelopment. The two core fatty acids found in grey matter are omega-3 which is DHA 
(docosahexaenoic acid) and arachidonic acid (omega-6, AA) (Benton, 2010). DHA accumulation 
in the brain and in other organs depends on the amount and types of omega-3  fatty acids in the 
diet, and on dietary intake of omega-6 fatty acids which interact and compete with omega-3 fatty 
acids in the fatty acid metabolic pathway (Guesnet & Alessandri, 2011; Innis, 2007). DHA is 
especially important as it is considered a building block of tissue in the brain (and retina), and it 
is responsible for forming neural transmitters, such as phosphatidylserine, which is important for 
brain function (Guesnet & Alessandri, 2011; Morse, 2012).  
EFA play a central role in brain tissue and modulate membrane fluidity and volume (de Souza, 
Fernandes, & do Carmo, 2011). These fatty acids regulate gene expression in the brain.  
Cognitive-nutritional research suggests that essential fatty acids are critical for brain development 
and function (Innis, 2007). EFA cannot be interconverted because human cells lack the converting 
enzyme omega-3 desaturase. They are not synthesized endogenously by humans and need to 
take place in the diet in order to provide the proper nutrients from fatty acids (Simopoulos, 2011).  
Most studies focus on the role of essential fatty acids, especially omega-3 polyunsaturated fatty 
acids (PUFA), perhaps due to omega 3 being a main component of brain cell membrane and 
critical for optimal brain development (Karr, Alexander, & Winningham, 2011). Cognitive 
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development is influenced by many factors and there is evidence that malnutrition can impair 
cognitive functions (A Nyaradi, Li, Hickling, Foster, & Oddy, 2013). However, there is not enough 
research to date investigating the association between dietary patterns and neurocognitive 
development (Anett Nyaradi, Li, Hickling, Foster, & Oddy, 2013).  
Maternal fish consumption (which is a rich source of omega-3) during pregnancy has been 
positively associated with cognitive development in offspring. It is important to examine the 
relationship between nutritional intake and cognitive development of the offspring because 
omega-3 supplementation may be a low-risk and cost-effective approach to improve some 
aspects of neurocognition. During the third trimester of pregnancy, fetuses require around 40-
60mg of omega 3 per kilogram body weight per day and the appropriate level of omega-3 is crucial 
in the last trimester due to rapid growth of the baby’s brain. During that time large amounts of 
DHA accumulate in the brain therefore indicating a demand for the nutrients (Bernardi et al, 2012).  
Cohort studies have reported that consumption of fish during pregnancy, especially oily fish 
containing Omega 3, is positively associated with better cognitive performance of their offspring 
(i.e., improved performance on tests of language and visual motor skills (Mendez et al 2009; Oken 
et al 2008) and higher scores on memory task (Mendez et al 2009). Moreover, Gale et al (2008) 
reported that children whose mothers had eaten fish in late pregnancy had a higher verbal IQ 
compared to offspring of mothers that did not eat fish. Higher consumption of fish oil in pregnant 
women is also linked to offspring’s better performance on digit span test which measures working 
memory (Boucher et al. 2011). There is some evidence suggesting  that prenatal fatty fish 
consumption (four times a week) has positive effects on the offspring’s cognitive abilities 
compared to mothers with no fish intake (at 18 months after birth) (Daniels, Longnecker, Rowland, 
& Golding, 2004). Helland et al. (2003) reported higher IQ at age 4 in children of mothers 
supplemented with cod liver oil (rich source of omega 3) from week 18 until 3 months after delivery 
than children of mothers supplemented with corn oil (n = 36; 106.4 [7.4] vs 102.3 [11.3]). Findings 
from observational studies provide a stronger support for more frequent fish intake during 
pregnancy and its association with improved offspring’s’ cognitive function. The randomized 
controlled trials (RCTs), however, provide mixed results (Oken & Belfort, 2010). For example, in 
the intention-to-treat analysis, supplementing pregnant mothers with omega 3 did not benefit 





1.4 Nutrients and health 
Nutrients are important not only for physical health, but also for optimal mental development and 
functioning. As reported by the World Health Organization (WHO), poor nutrition can lead to 
reduced immunity, increased susceptibility to disease, impaired physical and mental 
development, and reduced productivity (http://www.who.int/uv/faq/uvhealtfac/en/). 
1.4.1 The known effects of UV on human health  
Sunlight and vitamin D are the main exposures of interest in this thesis in chapter 4 and 5. 
Exposure to sunlight is thought to increase the brain’s release of a hormone called serotonin. This 
is associated with boosting mood and helping a person feel calm and focused (Young, 2007). In 
general, people have a feeling of wellbeing when exposed to sunlight. As early as in 1900s Finsen 
noticed that exposure to sunlight dramatically improved cutaneous skin lesions caused by a 
tuberculosis infection (lupus vulgaris) and received the Nobel Prize in 1903 for his enlightening 
observations. This led to the use of solariums with UVB radiation as a way to treat patients with 
tuberculosis and gave rise to the use of heliotherapy to improve health (Holick & Jung, 1999). The 
principal beneficial effect of sun exposure is its role in the production of vitamin D in the skin and 
it’s essential for healthy bone growth and maintenance (Holick, 2004; Sivamani, Crane, & 
Dellavalle, 2009; Webb, Decosta, & Holick, 1989; Wolpowitz & Gilchrest, 2006). Naturally 
occurring vitamin D is very rare in a human diet, it is present mainly in fatty fish and cod liver oil. 
However, short periods of midday sun exposure will produce sufficient vitamin D, and prolonged 
sun exposure will not provide additional benefits (www.who.int/uv/faq/uvhealtfac/en/). It has been 
suggested that one full body UV exposure causing a slight pinkness in skin (one minimum 
erythemal dose, 1 MED) is equivalent to an oral intake of somewhere in the range 250–625 µg 
(10,000–25,000 IU) of vitamin D3 (Engelsen, 2010). Additional studies supported the theory that 
one full-body exposure to sunlight can be equivalent to an oral vitamin D intake of 250 µg (10,000 
IU) (Vieth, 1999).  It has been suggested that the increase in serum 25(OH)D attained from 
exposure to UVB radiation is often more effective than ingesting 1000 IU vitamin D2 or vitamin 
D3 daily (Buettner & Raasch, 1998). 
Since it takes approximately 8 h for previtamin D3 in the skin to fully convert to vitamin D3 and it 
takes additional time for the vitamin D3 to enter the dermal capillary bed this is at least two of the 
explanations for why it was observed that vitamin D3 produced in the skin last 2–3 times longer in 
the circulation when compared with oral consumption (Haddad, Matsuoka, Hollis, Hu, & 
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Wortsman, 1993) Furthermore, when vitamin D3 is produced in the skin 100% of it is potentially 
bound to the vitamin D binding protein. When vitamin D3 is consumed in the diet or in a form of 
supplement it gets combined to chylomicrons which are transported into the lymphatic system 
and then into the venous system where approximately 60% of the vitamin D3 is bound to the 
vitamin D binding protein and 40% is rapidly cleared in the lipoprotein bound fraction (Haddad et 
al., 1993).Therefore, UVB is the most important for vitamin D production and lower vitamin D 
status is a marker for reduced sun exposure (Baggerly et al., 2015). 
There is increasing evidence that sunlight and vitamin D are linked to reduced cancer risk (Holick, 
2014). Epidemiologic and ecological studies have suggested that living at higher latitudes and 
having lower blood levels of 25-hydroxyvitamin D are associated with increased risk for up to 15 
types of cancers including breast, colon, lung, lymphoma, pancreatic, ovarian and prostate cancer 
(Grant et al., 2015; Holick, 2014). Other diseases caused (partially) by insufficient vitamin D or 
insufficient sunlight include diabetes, multiple sclerosis and heart disease (Grant, 2006; Holick, 
2004; Lips, van Schoor, & de Jongh, 2014; Sivamani et al., 2009). A possible relationship between 
vitamin D and blood pressure was reported by Rostand et al 1997. The results showed an inverse 
relationship between UV light and the prevalence of hypertension (Pilz, Tomaschitz, Ritz, & 
Pieber, 2009; Rostand, 1997). Further, it has been suggested that UVB (not UVA) light is linked 
to reduced blood pressure (Liu et al., 2014). Hypponen et al reported that children who received 
50 µg (2,000 IU) of vitamin D in the first year of life had 78% lower risk of developing type I 
diabetes (Hyppönen, Läärä, Reunanen, Järvelin, & Virtanen, 2001). In 1981, R. Edgar Hope-
Simpson proposed that a 'seasonal stimulus' closely associated with UV radiation explained the 
remarkable seasonality of prevalent influenza. Vitamin D deficiency is common in the winter, and 
activated vitamin D, 1,25(OH)2D, has profound effects on human immunity. An interventional 
study showed that vitamin D reduces the occurrence of respiratory infections in children. It was 
concluded that vitamin D, or lack of it, may be Hope-Simpson's 'seasonal stimulus' (Aloia & Li-
Ng, 2007; Cannell et al., 2006). These and other benefits of sun exposure led to a suggestion that 
the cardiovascular and other health benefits of UVB and vitamin D may outshine the risks of skin 
cancer. However, the WHO recommends small amounts of UV as essential for the production of 
vitamin D in humans, yet prolonged human exposure to solar UV radiation may result in acute 













1.4.1.1 UV exposure, vitamin D and mental health 
Convergent evidence from epidemiology, basic neuroscience, experimental animal models and 
clinical trials now connects low vitamin D status with an increased risk of a wide range of 
neurological and psychiatric disorders. Research demonstrates that the timing of exposure to low 
vitamin D influences the nature of brain phenotypes, as exposures during gestation versus 
adulthood result in different phenotypes. With respect to early life exposures, there is robust 
evidence from rodent experiments indicating that transient developmental vitamin D (DVD) 
deficiency is associated with changes in brain structure, neurochemistry, gene and protein 
expression and behaviour (Cui et al., 2014; J. J. McGrath, Burne, et al., 2010). In particular, DVD 
deficiency is associated with alterations in the dopaminergic neurotransmitter systems (Cui et al., 
2014). In contrast, recently published animal experiments indicate that adult vitamin D deficiency 
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is associated with more subtle neurochemical and behavioural phenotypes. Several studies have 
proposed functions for vitamin D in both in the developing (D. Eyles, Brown, Mackay-Sim, 
McGrath, & Feron, 2003) and adult brain (Garcion, Wion-Barbot, Montero-Menei, Berger, & Wion, 
2002; J. McGrath, 1999). It has been suggested that low levels of Vitamin D during early life may 
be relevant to several brain diseases such as schizophrenia (J. J. McGrath, Burne, et al., 2010). 
Schizophrenia has been associated with inadequate sun exposure and vitamin D deficiency and it 
is more common in the Scandinavian countries (Kinney et al., 2009). 
Furthermore, vitamin D has been associated with several psychiatric and developmental 
disorders (depression, schizophrenia, Autistic Spectrum Disorder) (Berk et al., 2007; Humble, 
2010; Schneider, Weber, Frensch, Stein, & Fritze, 2000). In a systematic review on the 
relationship between vitamin D deficiency and depression the authors concluded that, in a 
community setting, depressed adults had significantly lower serum concentrations of vitamin D 
than those without depression (Anglin, Samaan, Walter, & McDonald, 2013). 
 
1.4.2 Omega 3 and its effects on general and mental health 
Association of omega 3 (ω-3) consumption and certain diseases has been investigated especially 
in malnourished populations (consuming little ω-3). Research revealed significant relationship 
between ω-3 intake and heart disease, cancer (some cancer protective properties of omega-3) 
and diabetes mellitus (Karr et al., 2011). One study showed that individuals with a typical 
Mediterranean diet (rich in fish intake) performed significantly better on cognitive tasks than 
individual consuming less PUFA. The literature suggests some protective qualities of omega-3 
consumption, especially with relation to cognitive decline (Karr et al., 2011; Anett Nyaradi et al., 
2013). Morris and colleges (2003) reported effectiveness of ω-3 PUFA in treatment of Alzheimer 
disease and age related cognitive decline (Morris et al., 2003).   
There is some evidence for reduction in PUFA levels in patients with schizophrenia (Yao et al, 
1994; Berger et al, 2006) and major depressive disorder (Peet et al, 1998). Dietary deficiency of 
omega-3 fatty acids in humans has been related to increased risk of some mental disorders, 
including attention-deficit disorder, dyslexia, dementia, depression, bipolar disorder and 
schizophrenia (Adams, Lawson, Sanigorski, & Sinclair, 1996; Freeman et al., 2006; Gómez-
Pinilla, 2008; Peet, Murphy, Shay, & Horrobin, 1998). As mentioned before, folate and choline 
have a role in the closure of the fetal neural tube and prenatal folate deficiency causes neural 
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tube defects (NTD). The Californian mothers’ cohort study reported an increased risk of neural 
tube defects of their children with lower maternal choline intake (Shaw et al, 2004). The important 
finding of the negative effects of folate deficiency has led to worldwide fortification of foods with 
folate to prevent deficiency in pregnant women. Vitamin B12 has also been identified as an 
important nutrient for fetal development. One Chinese study showed that lower maternal levels 
of both folate and B12 significantly increased the risk of having a child with a NTD (Zhang et al, 
2009). 
Examining the research evidence on the relationship between nutrition and psychosis, evidence 
is limited and inconclusive. Studies have found that functional deficiencies or imbalances in 
certain fatty acids may contribute to a wide range of developmental and psychiatric conditions, 
including dyslexia, dyspraxia, and attention deficit hyperactivity disorder (ADHD), autism, 
depression, bipolar disorder and the schizophrenia spectrum (Karr et al., 2011). This is important 
especially at early age of development where research indicated that poor maternal nutrition 
during pregnancy is associated with lower cognitive functions and can lead to psychotic symptoms 
in their offspring (Hedelin et al., 2010). Further, a low maternal fatty acids intake during pregnancy 
is found to increase the risk for lower IQ and suboptimal neuro-developmental outcomes in 
childhood, factors that in turn are associated with an increased risk of adult mental disorder like 
schizophrenia (Hibbeln et al., 2007), for example, some studies reported significantly lower level 
of PUFA in patients with schizophrenia (Berger, Smesny, & Amminger, 2006). Based on limited 
and mixed results, it is important to further investigate the relationship between prenatal omega 
3 intake and its impact on the offspring cognitive development which in turn is associated  with 













Chapter 2 Methodological Innovations 
Here I describe several novel approaches and advanced statistical methods that I applied in my 
thesis.  
2.1 Comprehensive Meta-Analysis  
In this thesis, in chapter 3, I addressed the role of prenatal fish oil intake on childhood cognitive 
abilities using the Comprehensive Meta-Analysis software (CMA) version 3.0 (https://www.meta-
analysis.com ). In short, a meta-analysis method offers techniques to assist when combining 
results from different studies (Borenstein, Hedges, Higgins, & Rothstein, 2009). A meta-analysis 
is an important technique especially in situations when there is heterogeneity and inconsistencies 
in the different studies. By relating the study outcome to a variable available from several studies, 
outcome= b+b*X, a meta-regression can give better understanding of potential factors 
contributing to study differences.  
As for the CMA itself, the advantages of this particular software is its flexibility in working with 
many different sorts of data, its simplicity of use and its ability to customise and export forest plots. 
This version of CMA includes 100 formats for data entry and advanced computational options 
such as subgroup analysis, meta-regression and procedures to assess publication bias 
(Borenstein, Hedges, Higgins, & Rothstein, 2009). A typical drawback of meta-analyses approach 
is its retrospective nature since all analyses has been done already and adoption has to be made 
accordingly. 
2.1.1 Pooling results from randomised control trials and observational studies  
Randomized controlled trials (RCT) are described as the gold standard in the hierarchy of 
research designs for evaluating the efficacy and safety of a treatment intervention. However, their 
results can have limited applicability to patients in clinical settings (Silverman, 2009). 
Observational studies using large health care databases can complement findings from 
randomized controlled trials by assessing treatment effectiveness in patients encountered in day-
to-day clinical practice. Results from these designs can expand upon outcomes of randomized 
controlled trials because of the use of larger and more diverse patient populations with common 
comorbidities and longer follow-up periods. Furthermore, well-designed observational studies can 
identify clinically important differences among therapeutic options and provide data on long-term 
drug effectiveness and safety. However, they cannot rule out the possibility that the association 
32 
 
was caused by a third factor linked to both intervention and outcome (a confounder). In contrast, 
random allocation in RCTs ensures no systematic differences between intervention groups in 
factors, known and unknown, that may affect outcome. Double blinding ensures that the 
preconceived views of subjects and clinicians cannot systematically bias the assessment of 
outcomes (Sibbald & Roland, 1998). Observational studies cannot replace trials, nor do trials 
make observational studies unnecessary. Both designs are susceptible to particular bias, so 
neither provides perfect information (Sørensen, Lash, & Rothman, 2006). In this thesis I 
addressed the inconclusive results that come from both observational studies and randomized 
control trials by integrating study results. A systematic review and Meta-Analysis of combined 
results from RCTs and observational studies may be the next step towards understanding and 
estimating the association between maternal n-3 PUFA levels and childhood neurodevelopment, 
the topic introduced in chapter 3 of the thesis. 
2.1.1.1 Converting from the log odds ratio to d  
Meta-analysis is now used extensively in reviews of randomized controlled trials and 
observational studies, but the problems include how to compare non-identical outcomes. The 
following section explains the method used to convert from a log odds ratio (LogOR) to the 
standardized mean difference (SMD). This method was used in instances where studies reported 
different metrics and we needed to convert them to a common index before we could proceed 
with the synthesis. This simple method for converting an odds ratio to effect size explained here 
enables reviewers to maximize the information available. 
We used a basic method proposed by Hasselblad and Hedges (1995) to convert dichotomized 
outcome into continuous outcomes. Also variations of the method have been proposed by 
Sanchez-Meca, Martin-Martinez, & Chacon-Moscoso, 2003; Whitehead, 2002. The conversion 
method by Hasselblad and Hedges allows the direct conversion of odds ratios into SMDs. The 
method is based on the assumption that mean scores in each group follow a logistic distribution 
(i.e. a near normal distribution) and that variances are equal between groups. The basic formula 
is: 
SMD=LogOR×3√π  
where π is the mathematical constant (approximately 3.14159). 
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2.1.2 The concept of multiple outcomes analysis 
In the meta-analysis presented in this thesis, the studies reported data on more than one cognitive 
outcome, where the different outcomes are based on the same participants. Normally, separate 
meta-analyses would be performed, one using data for one outcome and the other using the data 
for another outcome etc. The Comprehensive Meta-Analysis software used to perform my meta-
analyses allows to incorporate all outcomes in the same analysis, meaning, we computed a 
summary effect for overall cognitive abilities which combines the data from all reported specific 
cognitive domains. The software takes into account that the data for specific cognitive abilities 
are not independent of each other and thus the errors are correlated (Borenstein et al., 2009). In 
general, treating each specific cognitive domain reported within one study as a separate study 
and performing a meta-analyses with multiple studies could be problematic (computing the 
summary effect across studies). This approach would assign more weight to studies with multiple 
outcomes than to studies with only one outcome. Further, this approach would lead to an incorrect 
estimate of the precision of the summary effect because it would treat specific domains as 
providing independent information and as we would assume the specific cognitive domains come 
from the same set of participants and are not independent of each other (Borenstein et al., 2009; 
Cooper & Hedges, 2009). Normally, the effects that one would like to combine are positively 
correlated therefore this method would tend to underestimate the error of the summary effect. A 
synthetic effect size for each study is created in order to compute a summary effect using multiple 
outcomes defined as the mean effect size in that study. This includes a variance that takes 
account of the correlation among the different outcomes. This effect size and variance is used to 
compute a summary effect across studies. Higher correlations yield less precise estimates of the 
summary effect. 
2.2 Quantile regression  
In statistics, regression is a common method used to obtain a summary of the relationship 
between a response variable y and a set of covariates x. For instance, a least squares regression 
captures how the mean of y changes with x of the outcome. Epidemiological research often 
focuses on inference for high or low values in a population distribution, e.g. high body mass index, 
low birth weight, high blood pressure. However in some instances, a single mean curve might not 
be informative enough particularly if the primary interest resides in the tail ends of the distribution. 
While linear regression speculates the question 'What is the relation between X and Y?' quantile 
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regression extends this to, 'For whom does a relation between X and Y exist' as well as testing 
for whom a relation is stronger or weaker" (Petscher & Logan, 2014). Quantile regression, as 
introduced by Koenker and Bassett (1978), is a method for estimating functional relations between 
variables for all portions of a probability distribution (Koenker & Bassett, 1978) . Further, a set of 
equally spaced quantiles (e.g. every 5% of the population) can define the shape of the distribution 
in addition to its central location. Thus, conditional quantile functions provide a more complete 
view. There are various reasons as to why one would choose to perform quantile regression, for 
example, when the distribution of y might be asymmetric around the mean or heteroscedasticity 
might exist in the data (Cade & Noon, 2003; McGreevy, Lipsitz, Linder, Rimm, & Hoel, 2009). For 
example, regression models with heterogeneous variances, which are common in 
epidemiological studies, imply that there is not a single rate of change that describes changes in 
the probability distributions, therefore, focusing only on changes in the means might 
underestimate, overestimate, or fail to distinguish real nonzero changes in heterogeneous 
distributions (Cade & Noon, 2003). 
I used quantiles to describe the distribution of the dependent variables. Quantiles and percentiles 
are synonymous where, for example, the 0.99 quantile would be the 99th percentile.  The best 
known quantile is the medium that is the 0.50 quantile. One practical consideration is that the 
distribution of the dependent variable is particularly important and that needs to be continuous 
with no zeros or too many repeated values.  
Unlike interpretation of linear regression, the interpretation of the quantile regression results need 
to specify which quantile of the dependent variable they refer to.  
There are numerous advantages of using the quantile regression. First of all, its flexibility for 
modelling data with heterogeneous conditional distribution. Secondly, the medium regression is 
more robust to outliers than the normal linear regression. Finally, the greatest advantage is that 
is has richer description of the data, it can show different effects of the independent variables on 
the dependent variables depending across the spectrum of the dependent variable.  
Since the data used for analysis in chapter 4 was highly skewed, we used analysis based on 




2.3 Missing data 
Missing observations caused by dropouts or uncompleted responses might cause a problem in 
studies of longitudinal data. When the analysis is restricted to complete cases and the missing 
data depend on previous responses, the generalized estimating equation (GEE) approach, which 
is commonly used when population-averaged effects are of primary interest, can lead to biased 
parameter estimates. There are also different approaches to address such problem, i.e. Multiple 
Imputation (Little & Rubin, 1987) or Multiple Imputation by Chained Imputation (White, Royston, 
& Wood, 2011). However, if only a relatively small proportion of the data contain missing values 
the records containing missing data can be deleted using only the complete cases in the analyses.  
Further, in the statistical literature missing data are usually classified according to the underlying 
reasons of being missing. If data is missing completely at random (MCAR), the probability of a 
value being missing is independent of both the observed data and the unobserved data, e.g. by 
tossing a dice, comparisons are generally not subject to bias. When, in a function Y= f(X) relating 
an outcome with exposure X, the probability of a particular value y being missing depends only 
on the observed data (Y or X), then the missing data is considered to be missing at random. If the 
missing data can be considered missing at random, the estimates obtained for the quantile 
regression, are unbiased. If this assumption is false, the missing data are not ignorable and the 
missing mechanisms should be modelled (Little & Rubin, 1987).  
In the work presented here using the large cohort of Swedish women the data used are 
essentially complete. Inverse-probability weighting (IPW) is more sophisticated method for 
handling missing data, which make the weaker assumption that the data are missing at random. 
We will apply this method to determine whether this method changes the conclusions of the 
original analysis.  
2.4 Data sources  
Apart from the Meta-Analysis, the data used for analysis in chapter 4 and 5 come from the 
Swedish Women’s Lifestyle and Health (WLH) cohort initiated in 1991 in Sweden. Detailed 
description of the Swedish cohort is provided in chapter 4 of this thesis.  
2.5 Statistical sources  
In this thesis I used two different statistical software. For the Meta-Analysis I used the 
Comprehensive Meta-Analysis Software version 3 which I briefly described in section 2.1.  
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The SAS software version 9.3 was used for studies included in chapter 4 and chapter 5. All of the 
statistical graphs and figures were produced using the SAS/GRAPH software. The QUANTREG 
procedure in the SAS software was used for the quantile regression models in the sun exposure 
and psychotic symptoms study. The LOGISTIC procedure was used for the sun exposure and 
depressive symptoms study in chapter 5.  
This thesis is written using the Word 2013. The references were managed using the open source 
Mendeley Desktop 1.15 software (https://www.mendeley.com ). 
2.6 The main objectives of the PhD project 
Recently, nutrition is gaining recognition as a potential environmental factor contributing to 
development of mental illness and moderating symptom severity. Research on nutrition and 
cognitive development, and psychiatric morbidity is limited and often inconsistent. The primary 
objective of the current PhD project is to conduct a rigorous evaluation of the association between 
dietary behaviour across critical periods of development and cognitive functions, psychosis and 
depression. The previous reports from Meta-Analysis published conflicting results. The research 
evidence from observational studies suggests that nutrients may play an important role in the 
cognitive development of children whereas results from RCTs are inconclusive and show less 
effect. In order to settle inconsistencies and conflicting results within and between the impacts of 
PUFA (fish oil) supplements/fish consumption in pregnancy on childhood cognition and 
behaviour, an intensive and careful systematic review and Meta-Analysis of epidemiological 
studies and RCTs is needed. In order to meet the objective the present study will look at the 
nutrition intake prenatally (Chapter 3) and for this reason a systematic review and Meta-Analysis 
of epidemiological studies and RCTs on PUFA supplements in pregnancy, and childhood 
cognition and behaviour will be conducted. I extracted more detailed data than previous reports 
focusing on specific domains of cognition, including Intelligence, language abilities, motor skills, 
memory, and reasoning, and examine the current evidence more specifically. By doing this the 
present research/evaluation can contribute to develop new concepts/hypothesis on the role of 
nutrition in general and specific neuropsychological functions in children. 
In the next sections, using the data from the Swedish Women Health Study (Roswall, Sandin, 
Adami, & Weiderpass, 2015), I looked at the link between sun exposure behaviours and vitamin 
D, and psychotic (Chapter 4) and depressive (Chapter 5) symptoms in adulthood. We examined 
further impact of nutrients on possible psychotic and depressive symptoms. The objective is to 
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look not only at PUFAS intake but also to investigate vitamin D (sun exposure behaviours) and 
the longitudinal relation between their exposure and psychotic and depressive symptoms in 
adults. This research will provide new and robust evidence for the ongoing debate on the role of 
nutrition through the lifespan as a possible risk factor for cognitive impairment and psychiatric 
illnesses. The Swedish Women's Lifestyle and Health cohort provides an opportunity to address 




Chapter 3 Fish Oil and Fish Intake during Pregnancy and 
Cognitive Functioning In Offspring: Systematic Review and 
Meta-Analysis of Randomised Control Trials and 
Observational Studies 
3.1 Summary  
The main objective of this chapter was to examine the effect of maternal fish oil intake and fish 
oil supplementation on offspring cognitive abilities by performing meta-analyses of randomized 
controlled trials and observational studies. PubMed, the Cochrane Library, ClinicalTrials.gov and 
reference lists were used to search for relevant studies. The Meta-Analysis included 8 randomized 
controlled trials that reported prenatal fish oil supplementation vs placebo and any cognitive 
outcomes in their children (average age 3 years old), and 5 observational studies that reported 
prenatal consumption of oily fish by pregnant women and any cognitive outcome of their children 
(average age 4.5 years old). The total number of participants in the RCTs was n= 1,433 and in 
the observational studies n= 16,391.The randomized controlled trials indicated better cognitive 
abilities in children of mothers in the fish oil supplementation group. For the measure of overall 
cognitive ability the standardized difference in means (SMD) was estimated to 0.10 (95% CI, -
0.01 to 0.20; p=0.07) and for memory functions the SMD was 0.21 (95% CI, 0.01 to 0.41; p=0.04). 
The observational studies showed better overall cognitive ability with a pooled OR of 1.92 (95% 
CI, 1.61 to 2.30; p<0.001) and for the domain of language and verbal skills the OR was 1.93 (95% 
CI, 1.37 to 2.73; p<0.001) among children of mothers consuming 2 to 3 fish servings per week 
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during pregnancy.  Maternal intake of fish oil during pregnancy is associated with improved 
cognitive abilities in the offspring. Specifically, fish oil is associated with advancement in language 
and memory abilities. 
3.1 Introduction   
Cognition represents a complex set of higher mental functions sub-served by the brain, and 
includes attention, memory, thinking, learning, and perception (Bhatnagar & Taneja, 2001). The 
literature suggests that cognitive development in children greatly depends on prenatal nutrition 
particularly in the third semester when the brain development begins. Omega-3 polyunsaturated 
fatty acid PUFA is a main component of the brain cell membrane and is critical for optimal brain 
development (Karr et al., 2011).While for some nutrients, absence may have no effect, for fatty 
acids this absence will have a negative effect. Particularly, brain function is critically dependent 
on the intake of the essential fatty acids that cannot be synthesized by the human body and can 
only be obtained from the diet. The requirements during pregnancy have not been well 
established, however, ISSFAL (the International Society for the Study of Fatty Acids and Lipids) 
has recommended 300 mg DHA daily as a minimum dosage for pregnant women 
(http://www.issfal.org/statements/adequate-intakes-recommendation-table). 
DHA (Docosahexaenoic acid) is the principal omega-3 (n−3) long-chain polyunsaturated fatty acid 
(LCPUFA). DHA is the end-product of the n-3 series, and is the predominant fatty acid of 
membrane phospholipids in the brain grey matter and in the retina of mammals (Guesnet & 
Alessandri, 2011). The time of the most rapid neural development occurs in the second half of 
pregnancy, mainly during third trimester. On this basis, supplementation of the maternal diet with 
omega-3 fatty acids, especially DHA, later in pregnancy is thought to be especially important 
(Jensen, 2006). 
Oily fish contains high concentrations of omega-3 polyunsaturated fatty acids. Several 
observational studies reported that consumption of oily fish (salmon, mackerel, sardines, and 
trout) may be beneficial for cognitive development of the offspring. (Daniels et al., 2004; Gale et 
al., 2008; Hibbeln et al., 2007; Oken & Bellinger, 2008) . There have been RCTs designed to 
assess the cognitive effects of omega-3 through the intake of fish oil but the results have been 
mixed (Campoy et al., 2011; Dunstan, Simmer, Dixon, & Prescott, 2008; Helland et al., 2008; 
Judge, Harel, & Lammi-Keefe, 2007; Makrides et al., 2010). Thus, integration of study results and 
careful examination of potential sources of heterogeneity is necessary.  
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To date there is no published Meta-Analysis evaluating both RCTs and observational studies on 
maternal PUFAs intake and child’s neurodevelopment. A Meta-Analysis published in 2013 
included only RCT designs and did not find any difference on cognitive abilities (including 
Developmental Standard Scores, IQ, and motor or language development) between the LCPUFA-
supplemented and control groups(Gould et al., 2013). Eleven RCTs were included in the review. 
Most trials had methodologic limitations. No differences in standardized psychometric test scores 
for cognitive, language, or motor development were observed between the LCPUFA-
supplemented and control groups, except for cognitive scores in 2-5-y-old children, in whom 
supplementation resulted in higher Developmental Standard Scores (mean difference: 3.92; 95% 
CI: 0.77, 7.08; n = 156; P = 0.01). However, this effect was from 2 trials with a high risk of bias. 
However the evidence did not conclusively support or refuted the possible positive effects of 
omega-3 supplementation in pregnancy on cognitive outcomes.  
The inconclusive results might be due to methodological limitations. Most RCTs only had a small 
or medium sample size, having low statistical power. Pooling of data using meta-analytic methods 
allows increasing statistical power.  Cognition is a multi-dimensional construct consisting of both 
general ability such as IQ, and specific cognitive abilities: memory, executive functions, and 
language. Different abilities are supported by different brain networks, but these have not been 
studied separately in detail. Animal studies have reported that n-3 deficiencies result in 
behavioural impairments observed in spatial learning, increased and disrupted motor activity and 
other learning tasks (de Souza et al., 2011).  
The objective of this Meta-Analysis is to test if maternal prenatal intake of fish oil is associated 
with offspring cognitive abilities. In particular, general as well as specific cognitive functions in 
both randomized controlled trials (RCT) and observational studies (OS).  
We hypothesized that better cognitive outcome will be present in children of mothers who 
consumed fish oil during pregnancy, particularly in specific cognitive outcomes.   
3.2 Methods 




1. All observational studies that present information on pregnant women’s fish intake and 
its effect on cognitive abilities of their offspring (including general cognitive abilities, IQ, 
motor skills, language, memory, reasoning) 
2. All RCTs that investigated the effects of fish oil supplementation during pregnancy on 
child cognitive abilities (including general cognitive abilities, IQ, motor skills, language, 
memory, and reasoning) 
We excluded 
1. Studies reporting further offspring supplementation, and physical (but not mental) 
development 
2. Studies not written in the English language 
3. Studies not reporting cognitive outcomes  
3.2.2 Literature search and selection 
The systematic review was planned and reported in accordance with the preferred reporting items 
for systematic reviews and meta-analyses (PRISMA) (Moher, Liberati, Tetzlaff, & Altman, 2009) 
The medical literature was searched using PubMed, the Cochrane Library, ClinicalTrials.gov and 
reference lists. 
Studies on prenatal fish oil intake and children cognitive abilities were identified using the terms 
“nutrition”’ together with “pregnancy” and “cognition”  
Search details through PubMed MESH search: 
("nutritional status"[MeSH Terms] OR ("nutritional"[All Fields] AND "status"[All Fields]) OR 
"nutritional status"[All Fields] OR "nutrition"[All Fields] OR "nutritional sciences"[MeSH Terms] OR 
("nutritional"[All Fields] AND "sciences"[All Fields]) OR "nutritional sciences"[All Fields]) AND 
("pregnancy"[MeSH Terms] OR "pregnancy"[All Fields]) AND ("cognition"[MeSH Terms] OR 
"cognition"[All Fields]) 
Database search was completed by a researcher (IP). Studies were assessed against the 
inclusion criteria by the researcher (IP), first using the titles, then using the abstracts, and finally 
using the full text.  
A total of 8 randomized controlled trails; (Campoy et al., 2011; Dunstan et al., 2008; Helland et 
al., 2008; Helland, Smith, Saarem, Saugstad, & Drevon, 2003; Judge et al., 2007; Makrides et al., 
2010; Meldrum, Dunstan, Foster, Simmer, & Prescott, 2015; Tofail et al., 2006) and 5 
observational studies that met our inclusion criteria were found (Daniels et al., 2004; Gale et al., 
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2008; Hibbeln et al., 2007; Mendez et al., 2009; Oken & Bellinger, 2008). The summary estimate 
was based on the reported means and standard deviation, sample size or odd ratios (ORs) and 
95% confidence intervals (CIs). We also contacted the authors of the papers in case of missing 
mean values for cognitive outcomes (Gale et al., 2008; Oken & Bellinger, 2008). 
Studies included in this review were randomized controlled trials (RCTs) and observational 
studies in humans, with English-only text, with no limitations set for date of publication. The last 
search was completed in March 2015. The review author (IP) assessed the titles, abstracts and 
the full text of the article for study eligibility. Additionally, reference lists of selected articles were 
searched for citations according to the inclusion criteria. We excluded studies with infant 
supplementation and studies that did not reported cognitive measures. 
Predefined cognitive outcomes (intelligence, language, motor skills, memory, and reasoning) 
were extracted blindly by the first author according to the available cognitive outcomes in included 
studies. The authors (IP, AR) assessed the outcome measures and reclassified the cognitive 
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Additional records identified through 
reference list of identified records 
(n= 5)  
 
Records after duplicates removed  
(n = 110) 
Review abstracts + titles  
(n = 110) 
Records excluded  
(n =60) 
• not preferred 
design 
 
Full-text articles assessed for 
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(n = 50) 
Full-text articles 
excluded  
(n = 11) 
• No cognitive 
outcomes 
reported 
Studies included in qualitative 
synthesis  
(n =39) 
Studies included in Meta-Analysis 
 
(RCTs n = 8; Observational 
studies n= 5) 
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3.2.3 Measurements and variables 
Measurements and variables included in the present meta-analysis are listed in Table 2 in results 
section. We included the cognitive domain variables:  general intellectual ability (IQ), language, 
motor skill, memory and reasoning. 
Demographic characteristics, study duration, dosage and dropout rates were first extracted. The 
core data in each RCT study consisted of the sample size, the mean values of relevant continuous 
cognitive variables and their SDs in the placebo and treated groups. When this information was 
not available, instead we extracted the sample size for each treated and placebo group, mean 
value and the corresponding P value of the statistical test used to estimate the standardized mean 
difference.   
From the observational studies we extracted OR and confidence limits.(Daniels et al., 2004; 
Hibbeln et al., 2007; Oken & Bellinger, 2008) In the observational studies where the ORs were 
not available we instead extracted means and standard errors and number of participants for each 
group (fish intake 2 to 3 times per week vs no fish intake).(Gale et al., 2008; Mendez et al., 2009; 
Oken & Bellinger, 2008) As comparison to the women who did not consume any fish we decided 
to compare the most commonly reported frequency of fish intake which was 2 to 3 servings/week.  
3.2.4 Quality assessment of the included clinical trial 
All RCTs were double-blinded in this review however none of the RCTs described blinding 
methods. Except for 1 study (Judge et al., 2007) all provided a description of an account of all 













Table 1 The Jadad scale for quality review of randomized controlled trials. 
 
Source Randomization 


























Judge et al 
2007 
1   1    2 
Campoy et al 
2011 
1 1  1   1 4 
Makrides et al 
2010 
1 1  1   1 4 
Helland et al 
2003 
1   1   1 3 
Helland et al 
2008 
1   1   1 3 
Tofail et al 
2006 
1   1   1 3 
Dunstan et al 
2006 
1 1  1   1 4 
Meldrum et al 
2015 
1 1  1   1 4 




3.2.5 Additional data 
The authors of three included studies where some cognitive outcomes were missing (Gale et al., 
2008; Hibbeln et al., 2007; Oken & Bellinger, 2008) were contacted and the information was 
provided via email (table of means provided by Gale et al).  
3.2.6 Statistical Methods 
From the extracted data we calculated the pooled effect size in the form of SMD (standardized 
mean differences) for RCTs and two OS, and the pooled odd ratios for the remaining OS 
separately. All analyses were performed using the Comprehensive Meta-analysis version 3 
software package (www.meta-analysis.com). Comprehensive Meta-analysis version 3 includes 
a module that enables the analysis of multiple outcomes from the same study. For example, 
multiple outcomes analysis allows including effects of several outcomes accounting for correlation 
among the different outcomes whereas the same participants and the information for the different 
effects are not independent from each other. This module was used to derive an estimate for the 
overall cognitive outcomes. Heterogeneity among study point estimates was assessed with Q 
statistics with magnitude of heterogeneity being evaluated with the I2 index. Weighted mean effect 
sizes were computed under both fixed- and random-effects meta-analytic assumptions; 
homogeneity analyses (Q and I2) followed fixed-effects assumptions for combined analysis and 
random effects models for multiple outcomes analysis. Meta-regression was used to assess the 
effects of potential moderators.  
3.2.7 Statistical analysis – randomised control trials  
The first step involved calculating for each cognitive domain and each study the effect sizes for 
the difference between supplemented and placebo groups, including intelligence, language, 
motor skills, memory, and reasoning. We analysed differences between the fish oil group vs 
placebo group for each cognitive domain group separately. Overall cognitive abilities were also 
considered by analysing the difference between the fish oil vs placebo for combined cognitive 
outcomes using the multiple outcomes module. 
3.2.8 Statistical analysis - Observational studies 
The first step involved calculating for each cognitive domain and each study the effect sizes for 
the difference between women who reported fish consumption and women with no fish 
46 
 
consumption, including intelligence, language, motor skills, memory, and reasoning. The meta-
analysis analysed differences between the fish consumption group vs no consumption group for 
each cognitive domain group separately.  Overall cognitive abilities were also considered by 
analysing the difference between the two groups for overall cognitive outcomes using the multiple 
outcomes module. 
3.2.9 Moderator analysis 
Potential sources for study heterogeneity were examined using meta-regression analysis. Meta-
regression was performed under the random effect model in order to test the impact of two 
covariates separately. We included initial DHA prenatal dose (mg/week) (RCTs), and child's age 
(in months) at study inclusion (observational studies) as potential moderating variables.  
3.2.10 Sensitivity analysis  
We assessed publication bias with Begg’s funnel plot and Egger’s test. If publication bias exists, 
the Begg’s funnel plot is asymmetric or the Egger’s test P value is <0.05. In this way, we assessed 
whether there was a tendency for selective publication of studies based on the nature and 
direction of their results.  
In addition, we used the fail-safe procedure to generate the number of unpublished studies that 
would be needed to move estimates to a non-significant threshold. To assess the robustness of 
the results, we performed sensitivity analyses by sequentially removing each study and rerunning 
the analysis. 
We performed Meta-Analysis of observational studies based on the conversion from odd ratios 
to standardized mean difference. We used a method proposed by (Hasselblad & Hedges, 1995) 
to convert dichotomized outcome into continuous outcomes. The conversion method by 
Hasselblad and Hedges allow the direct conversion of odds ratios into SMD. The method is based 
on the assumption that mean scores in each group follow a logistic distribution (i.e. a near normal 
distribution) and that variances are equal between groups. The formula is:  






Table 2 shows the characteristics of the study populations for both RCTs and observational 
studies. 
Both effect size models, fixed and random, were identical for RCTs (T2=0) therefore for the 
remainder of this paper, only results of the fixed effects model will be presented.  
For observational studies, heterogeneity was not statistically significant, Q (6) =4 (p=0.19) and 
I2=34.3, indicating that 34.3 % of the data variance was due to variation between the studies.  
The results were expressed as standardized mean difference (SMD) (for studies reporting mean 
values), because different instruments were used to measure the cognitive abilities. For 













Country  Design Sample size/characteristics 
of the mothers of children 












Judge et al. 
2007 
USA RCT 29 pregnant women aged 18-
35 at <20 wk of gestation 
 214mg of DHA/d 
from week 24 until 
delivery or corn oil 
(placebo) 
9 months  Problem solving and 
recognition memory 
measured by The 













RCT 82 pregnant women aged 18-
40 at <20 wk of gestation 
DHA 500 mg/d   or 
(n=45) placebo/d until 
delivery 
6.5 years  Memory, reasoning 
and intelligence 
measured by The 
Kaufman Assessment 









RCT 694 pregnant women aged at 
<21 wk of gestation 
(n=351) DHA 800 
mg/d or (n=375) 
placebo (vegetable 
oil) 
18 months  Cognitive and 
language 
development 
measured by The 
Bayley Scales of 




Cognitive scores as 
an index for IQ 
Helland et 
al. 2003 
Norway RCT 84 pregnant women aged 19-
35 in week 18 of pregnancy 
(n=48) DHA 
1183mg/d or (n=36) 
placebo (corn oil) 
4 years  Memory, reasoning 
intelligence and 
nonverbal abilities 
measured by The 
Kaufman Assessment 








Norway RCT 143 pregnant women aged 19-
35 in week 18 of pregnancy 
(n=82) DHA 
1183mg/d or (n=61) 
placebo (corn oil) 
7 years Memory, reasoning 
intelligence and 
nonverbal abilities 
measured by The 
Kaufman Assessment 








RCT 249 pregnant  women Mean 
age 22.1 at 25 weeks of 
gestation  
(n=125) DHA 1200 
mg/d or (n=124) 
placebo (soy-oil) 
10 months  Bayley Scales of 
Infant Development II 







for intelligence and 
Psychomotor 
developmental 
index for measures 
of Motor Skills  
Dunstan et 
al. 2006 
Australia RCT 72 pregnant women at <20 wk 
of gestation  
(n=31) DHA 2200 
mg/d or (n=39) 
placebo (olive-oil) 
2.5 years Griffiths’ Mental 
Development Scale 
for developmental 
quotients  and 
Peabody Picture 
Vocabulary (PPTV) 
for receptive language 
PPTV for language; 
General quotient 
score for IQ; 
Practical reasoning 
for reasoning and 
Locomotor for 




RCT 72 pregnant women at <20 wk 
of gestation  
(n=25) DHA 2200 
mg/d or (n=25) 
placebo (olive-oil) 




speed and full scale 
















117 pregnant women aged >= 
16 years at <17 wk of 
gestation who completed FFQ 
Food Frequency 
Questionnaire (FFQ) 
in the 3 proceeding 
months; Fish intake 
categories: Never 
(n=62) Less than 
1/wk (n=100) and 
<=1/wk (n=55) 
9 years  The Wechsler 
Abbreviated Scale of 
Intelligence 
(Wechsler, 1999) for 
full scale IQ and 
Verbal IQ 
2 categories of fish 
intake: Never vs 
1/wk or more for 







5449 mothers with FFQ 
reports and cognitive data 
FFQ at 32 wk 
gestation  
8 years  IQ measured by the 
Wechler Intelligence 
Scale for Children 
III(WISC-III)  
2 categories of fish 
intake: None vs 
>340g/wk (up to 3 
times/wk) for full 








10,092 pregnant women at 32 
wk of gestation completed 
FFQ 
FFQ at 32 wk 
gestation; Fish intake 
categories: 
Rarely/Never; 1 meal 

























392 women at 3 months after 
delivery completed FFQ on 
fish intake during pregnancy;  
Fish intake 
categories: <=1time 
/wk, >1-2 /wk, >2-
3/wk,>3/wk 
4 years old The Spanish version 
of the McCarthy 
Scales of Children's 
Abilities (MCSA) tests 
(perceptual 
performance, 
memory, verbal and 
motor) 
 2 categories of fish 
intake frequency: 
<1 vs >2-3/wk for 
scores on Memory, 
Verbal skills, Motor 
skills and general 






studies for this 
Meta-Analysis) 










Never, <=2, and >2 
times/wk 
3 years PPVT for receptive 
language and The 
Wide Range 
Assessment of Visual 
Motor Ability 
(WRAVMA) visual 
motor skills and fine 
motor skills (Peabody 
test) 
2 categories of fish 
intake: Never vs 
>=2/wk for scores 
on PPVT-language 





3.3.1 Overall cognitive outcome 
Figure 5 presents overall and individual cognitive outcomes results of RCTs for children cognitive 
abilities after maternal fish oil supplementation. The overall cognitive measures analysis revealed 
that prenatal fish supplementation (compared with placebo) had an effect size (SMD) of 0.10 
(95% CI, -0.01 to 0.2; p=0.07) on children cognitive functions.  
Figure 6 presents the overall summary effect size (observational studies) for maternal fish intake 
2 to 3 times a week vs no fish intake and children cognitive outcomes for studies reporting the 
odd ratios and mean values. The results are presented separately and were statistically 
significantly different with pooled odd ratios of OR of 1.92 [95% CI, 1.61-2.30]; p<0.001) and 
approaching statistical significance for OS reporting mean values SMD of 0.22 [95% CI, 0.02 to 
0.45]; p=0.07).  
3.3.2 Intelligence 
Only one of eight RCTs reported statistically significant effect for general intelligence (Helland et 
al., 2003) with a SMD of 0.44, 95% (CI) - 0.01 to 0.88; p=0.05. The combined effect for all eight 
RCTs was not statistically significant for general intelligence. The only data available from 
observational studies was on verbal intelligence and reported by a single study.(7) The overall 
effect was statistically significant with OR estimated to 1.92, 95% (CI) 1.72 to 2.71, p<0.001.  
3.3.3 Language and verbal skills  
For RCTs, three studies reported data on language domain and the effects were not statistically 
significant (Figure 5). The combined effect for three RCTs was approaching statistically significant 
effect with SMD of 0.13, 95% (CI) -0.01 to 0.26, p=0.06. Three observational studies reported odd 
ratios for the verbal skills domain and the results showed statistically significant effect (Daniels et 
al., 2004 and Oken et al., 2008) OR=1.92, 95% (CI) 1.61 to 2.30, p<0.001 and two OS reported 
mean values for the language domain and the effect was approaching statistically significant 




3.3.4 Memory, motor skills and reasoning  
Figure 5 shows statistically significant results in the memory domain for RCTs with an effect size 
of SMD 0.21 (95% CI, 0.01 to 0.41; p=0.04). No data from observational studies was available to 
estimate an effect for the memory domain.  
The remaining analysis on the effects on specific cognitive domains (motor skills and reasoning) 






























Figure 5 Meta-Analysis of prenatal fish oil supplementation and the effects on overall and specific cognitive 














Figure 6 Meta-Analysis of prenatal fish intake two to three fish servings per week vs no fish intake and the 









3.3.5 Meta-regression  
Meta-regression found no effect for age at assessment or DHA dosage in mg per week on 
offspring cognitive abilities.  
 
3.3.6 Sensitivity analysis 
Judged from the Funnel plot and the corresponding Egger's test there was no evidence for 

































Figure 7 Funnel plot of standardized difference in means by Fisher’s Z from Meta-Analysis of RCTs 
comparing prenatal fish oil intake and the overall effects on children cognitive outcomes. In the absence of 







Figure 8 Funnel plot of standard error by Fisher’s Z from meta-analyses of observational studies comparing 
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Figure 9 presents the overall summary effect size (observational studies) for maternal fish intake 
2 to 3 times a week vs no fish intake and children cognitive abilities for studies reporting the odd 
ratios and the mean values. The odd ratios were converted into SMD using the method described 
in the method section (sensitivity analysis section) and were statistically significantly different with 






Figure 9 Meta-Analysis of prenatal fish intake two to three fish servings per week vs no fish intake and the 
effects of cognitive abilities of the offspring from five observational studies. 
 
 
Note: We used a basic method suggested by Hasselblad and Hedges (1995) to convert dichotomous 
outcome into continuous outcomes. The method is based on the assumption that mean scores in each group 










In this comprehensive, up to date review of all available literature, we found that prenatal fish oil 
was associated with better cognitive abilities in the offspring. Although, the results were not 
statistically significant, we found concordance across reviewed study designs where RCTs 
supported the results of the observational studies on this topic.  
Evaluations of eight randomized control trials found the results approaching statistical significance 
towards better cognitive functions among children of mothers in fish oil intervention groups.  
Examination of specific cognitive outcome showed that fish oil was particularly beneficial for 
memory functions. Analyses of observational studies suggest that consuming fish 2-3 times a 
week, which was the most common category of fish consumption by pregnant women in the 
selected studies, is beneficial for optimal cognitive development of the offspring specifically for 
domains related to language and verbal skills.  
To the best of my knowledge, no previous Meta-Analysis has addressed the problem of 
presentation of results in a domain-specific way comparing results from epidemiological studies 
and randomized control trials. A domain-specific presentation of results was incorporated based 
on the available cognitive domains from published research studies. It should be acknowledged 
that there is currently only limited information on which specific cognitive abilities are omega-3 
sensitive, and there are no common standardized sets of cognitive tests used in nutritional 
studies. The present finding on better memory and language abilities in children whose mothers 
consume fish oil in pregnancy could be a potential direction for future studies on this topic.  
Starting with the RCTs included in the present study, a number of factors could contribute to the 
small effects. There was inconsistent dosage across selected studies. The studies included in 
this Meta-Analysis used various dosages (between 214mg/day to max. 2200mg/day). Currently, 
the recommended DHA minimum dosage for pregnant women is 300mg per week. One of the 
RCT included in this Meta-Analysis used the intervention dosage below the minimum 
recommendation (214mg/d).(Judge et al., 2007) Therefore this could have an impact on the 
magnitude of the effects from the present analysis. We performed meta-regression of DHA 
dosage in RCTs but did not find statistically significant results. Visual assessment of the results 
suggested that higher dosage could be more beneficial.  
Another potential factor contributing to small effect sizes could be the cognitive assessment 
chosen. Inconsistent results may be due to the use of different measures of cognitive functions in 
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the current literature. Measurement methods must be homogeneous, sensitive, and specific for 
the different areas of neurodevelopment and this should be considered in future studies on the 
topic. Also it should be noted that one of the studies used the Fagan Test of Infant Intelligence 
(Judge et al., 2007). It should be kept in mind that the Fagan test has been developed for the 
early detection of later mental retardation and should not be used for routine screening with 
normal populations. In clinical use, the Fagan test should only be given to infants suspected to 
be at risk for later cognitive deficit (this could account for an incorrect used of the test battery in 
the study by Judge et al 2007).  
The present study examined specific cognitive domains (not only overall cognitive function) and 
we found language and memory functions to be sensitive to prenatal intake of DHA in children. 
Future studies should carefully select cognitive measures to assess language and memory 
cognitive domains. General and specific cognitive domains should be evaluated.  
A recent Meta-Analysis (Gould et al., 2013) compared the effect of fish oil on child language 
development and reported that language development showed no differences between the 
intervention and placebo groups which is contradictory to the results of the present study. Daniels 
et al reported that higher maternal fish consumption was associated with better language skills in 
7421 British children assessed at 15 months. (Daniels et al., 2004) Oken et al reported that 
although higher fish intake may result in higher erythrocyte mercury concentration, research in 
American schoolchildren demonstrated that higher maternal fish intake was positively associated 
with improved language scores on the Peabody Picture Vocabulary Test (PPVT), after adjustment 
for multiple potential confounding covariates.(Oken & Bellinger, 2008) 
Another factor that could affect the magnitude of the effect sizes was different age at 
assessments:  seven of the twelve studies assessed the neurodevelopment of children at or after 
3 years of age and these studies showed no benefit of n-3 LCPUFA supplementation up until 7 
years of age. For example, Helland et al reported positive effect of DHA on intellectual abilities of 
children.(Helland et al., 2003) The present Meta-Analysis performed a meta-regression of the 
effect of ‘age at assessment’ on cognitive abilities and found no statistically significant moderating 
effect.  
These results, like those of any Meta-Analysis, should be viewed with caution. Meta-regression 
is a form of observational association and therefore cannot be used to make casual inferences 
about the data (Higgins & Thompson, 2004) however in the present study I found no effect for 
age at assessment or DHA dosage in mg per week on offspring cognitive abilities. 
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The overall consistency of our findings, regardless of study type, is reassuring. The only major 
source of bias identified in RCTs was that only four studies reported data for completers.  
Assessment of dietary intake of fish, by food frequency questionnaires in observational studies, 
can be associated with a considerable degree of measurement error even when using validated 
methods. This is probably one explanation why a dose-response effect could not be shown 
between change in dietary intake and magnitude of cognitive scores change. 
As confirmed above, the more consistent results were obtained in observational studies and can 
be explained by the possibility that fish, as a whole food, contains other nutrients important to 
cognitive development (A Nyaradi et al., 2013). However, the long-term effects of fish oil on 
children’s cognitive abilities remain unknown. More research is needed to identify the importance 
of prenatal intake of omega-3 and the effects on children cognitive abilities.  
3.4.1 Conclusion 
Intake of fish oil (supplementation or consumption of fatty fish) by pregnant women is positively 
associated with cognitive abilities in their offspring. Specifically, fish oil is associated with 
















Chapter 4 Sun Exposure, Vitamin D and Psychotic Experiences 
4.1 Summary  
Sun exposure is considered the single most important source of vitamin D. Vitamin D deficiency 
has been suggested to play a role in the aetiology of psychotic disorders. The aim of the present 
study was to evaluate the association between sun exposure and psychotic experiences in a 
general population sample of Swedish women. The study population included participants from 
The Swedish Women's Lifestyle and Health cohort study. The 20-item Community Assessment 
of Psychic Experiences (CAPE) was administered between ages 30 and 50 to establish psychotic 
experiences. Sun exposure as measured by 1) sunbathing holidays and 2) history of sunburn was 
measured between ages 10 to 39.  The association between sun exposure and psychotic 
experiences was evaluated by quantile regression models. 34 279 women were included in the 
analysis. Women who reported no sunbathing holidays and two or more weeks of sunbathing 
holidays scored higher on the CAPE scale than women exposed to one week of sunbathing 
holidays across the entire distribution, when adjusting for age and education. Similarly, compared 
with women who reported a history of one sunburn, the women with none or two or more sunburns 
showed higher scores on the CAPE scale with more women in the right part of the distribution. 
The findings of this study suggest that in a population based cohort of middle aged women, both 
low and high sun exposure is associated with increased level of positive psychotic experiences. 
 
4.2 Introduction 
Schizophrenia and other psychotic disorders are lifelong neuropsychiatric conditions that affect 
2- 3% of the population (J. J. McGrath et al., 2015; Perälä et al., 2007). The characteristics of 
psychosis are altered perception (hallucinations) and changes in the form and content of thoughts 
and speech (delusions and thought disorder). Symptoms typically begin in late adolescence or 
early adulthood. Schizophrenia has frequently been associated with abnormalities in the 
dopaminergic system (Jim van Os & Kapur, 2009). 
Vitamin D is an essential nutrient that plays an important role in many biochemical functions that 
contribute to ageing, including bone renewal, cell proliferation, hormone balance, and 
cardiovascular and glucose metabolism (Berridge, 2015). Of particular interest is accumulating 
evidence for the actions of vitamin D in the brain (D. Eyles et al., 2003; Holick & Chen, 2008). 
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Animal studies have demonstrated that prenatal vitamin D deficiency is associated with persistent 
changes in adult brain structure, neurochemistry, and behaviour (Burne et al., 2004; D. Eyles et 
al., 2003). Evidence now links low vitamin D levels with reduced cognitive performance (Annweiler 
et al., 2010), increased risk for cancer, diabetes, cardiovascular disease, and death (LeBlanc, 
Chou, Zakher, Daeges, & Pappas, 2014; Pludowski et al., 2013) 
The main source of vitamin D for humans is from its dermal synthesis by exposure  to sunlight 
(Lips et al., 2014; Touvier et al., 2015) which provides up to 90% in the form of  vitamin D3 
(cholecalciferol) with the remainder coming from food in the form of vitamin D3 or vitamin D2 
(ergocalciferol) (Holick, 2004; Holick & Chen, 2008; LeBlanc et al., 2014; Umhau et al., 2013). 
Solar ultraviolet B radiation with a wavelength between 290 and 315 nm, penetrates the skin and 
converts 7-dehydrocholesterol to pre-vitamin D3, which then is isomerized by heat to vitamin D3 
before being carried, bound to vitamin D binding protein, to the liver where it is converted into the 
main metabolite 25-hydroxyvitamin D3. Prolonged sun exposure does not result in the production 
of excess quantities of vitamin D3 to cause intoxication. Moreover, it has been argued that 
prolonged exposure can break down vitamin D, reducing health benefits and increasing risk of 
skin cancer (Holick, 2004). Therefore, it has been suggested that moderate sun exposure is as 
effective as long sun exposure for previtamin D production (Sivamani et al., 2009). It has been 
proposed that the increase in serum 25(OH)D attained from exposure to UVB radiation is often 
more effective than consumption of 1000 IU vitamin D2 or vitamin D3 daily (Buettner & Raasch, 
1998). 
Murri et al reported in a Meta-Analysis that individuals with psychosis showed statistically 
significantly lower vitamin D levels than healthy controls (Belvederi Murri et al., 2013). Vitamin D 
has been found to modulate dopamine neurotransmission (D. Eyles et al., 2003) and several 
studies reported an association between early life vitamin D deficiency and later psychotic 
disorder. Vitamin D deficiency around birth has been associated with increased risk for later 
schizophrenia in a Danish population-based study (J. J. McGrath, Eyles, et al., 2010). McGrath 
and colleagues reported that both low and high concentrations of neonatal vitamin D were 
associated with increased risk of schizophrenia. Similarly, lack of vitamin D supplementation 
during the first year of life was found to be associated with later schizophrenia (J. McGrath et al., 
2004). However, other studies have failed to find a statistically significant association (Norelli, 
Coates, & Kovasznay, 2010; Schneider et al., 2000). While there are many studies reporting the 
association between vitamin D levels in the blood samples (J. McGrath et al., 2004; J. J. McGrath, 
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Eyles, et al., 2010), there is still a lack of studies on sun exposure, the main source of vitamin D  
in most countries. Only one study has reported on the relationship between sunlight exposure 
and schizophrenia incidence, but found no association. This study was limited in power and did 
not measure sun exposure at the individual level but instead used average sun exposure for a 
larger geographic area as their exposure (Kendell, 2002). Thus, the association between vitamin 
D, sun exposure and psychosis remains debated. 
Evidence suggests that subclinical psychotic experiences might be on a continuum with psychotic 
disorders. Psychotic experiences are present in 5-15% of individuals from the general population 
(J. J. McGrath et al., 2015; J van Os et al., 2009) and share risk factors with psychotic disorders, 
including social adversity (e.g., low SES, urbanicity) (J van Os et al., 2009) and cognitive 
impairment(Simons, Jacobs, Jolles, van Os, & Krabbendam, 2007). Imaging studies have also 
revealed pathophysiological overlaps between psychotic disorders and subclinical psychosis. 
Moreover, the occurrence of psychotic experiences in early life is associated with increased risk 
of later psychotic disorders. Psychotic experiences have also been associated with a wider range 
of common mental health problems, including anxiety, depression, substance misuse, suicide risk 
and self-harm (Olfson et al., 2002; Rössler et al., 2011; Saha et al., 2011; Saha, Chant, Welham, 
& McGrath, 2005; J van Os et al., 2009) 
Because psychotic experiences are common and associated with a range of adverse health 
outcomes (J. J. McGrath et al., 2015; J van Os et al., 2009) it is important to study them. Moreover, 
since individuals with psychotic experiences generally do not receive anti-psychotic medications 
potential confounding by medication is avoided.  
Given the limited research, the aim of this study is to investigate the association between adult 
life sun exposure (as a proxy for vitamin D status) and later psychotic experiences. Using a large, 
prospective, population based, cohort study, we tested the hypothesis that sun exposure 
behaviours predict later psychotic experiences.  
4.3 Methods 
4.3.1 Study Population 
4.3.1.1 Who is the cohort? 
The purpose of the Woman Lifestyle and Health (WLH) study was to create a large prospective 
cohort designed specifically to investigate the association between lifestyle factors (including 
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dietary habits) and cancer and cardiovascular disease in young women. Other outcomes have 
also been investigated, including overall mortality and psychiatric conditions. 
The WLH study was co-funded by the Swedish Medical Products Agency, the Swedish Cancer 
Society and three pharmaceutical companies. The ongoing analyses and the follow-up 
questionnaire were funded by the Swedish Cancer Society and the Swedish Research Council. 
Between 1991 and 1992, women were invited to participate in the WLH study. Inclusion criteria 
were age between 29 and 49 years (born between 1943 and 1962) and residence in the Uppsala 
Health Care Region, which comprises approximately one-sixth of the Swedish population. 
Altogether, 96 000 women were randomly selected from the Swedish Population Registry at 
Statistics Sweden based on their unique, 10-digit national registration number, which includes 
information on both date of birth and sex. The responsible data monitoring board and the ethical 
committee in Sweden approved the study design, and all women gave informed consent to 
participate in the study. The women were mailed an invitation to the study, along with the baseline 
questionnaire, which included a food frequency questionnaire. In total, 49 259 women (51%) 
completed and returned the baseline questionnaire, and were thus included in the final cohort. 
The median age at enrolment was 40 years, meaning that most women were premenopausal at 
the time of enrolment. The cohort is generally well-educated, with 68% having completed more 
than 10 years of schooling, and they also led a generally healthy lifestyle. The median BMI at 
baseline was 23, only 21% were smokers and only 4% fell into the lowest category of physical 
activity. Alcohol intake in the cohort was also quite low at baseline, with a median intake of 2.27 















Table 3 Baseline characteristics of participants in the Women’s Lifestyle and Health cohort, entire cohort 










Non-responders to the 
follow-up questionnaire 
N = 14 857 
Age at enrolment, 
years 
40 (32–48) 40 (32–48) 40 (32–48) 
BMI, kg/m2 23 (20–28) 22.5 (20–28) 23 (20–28.5) 
Missing, N (%) 2024 (4.11%) 1213 (3.53%) 811 (5.46%) 
Smoking status, 
N (%) 
Never 20 476 (41.57%) 14 682 (42.68%) 5794 (39.00%) 
Former 18 287 (37.12%) 12 821 (37.27%) 5466 (36.79%) 
Current 10 496 (21.31%) 6899 (20.05%) 3597 (24.21%) 
Education, N (%) 
0–10 years 14 491 (30.08%) 9160 (27.16%) 5331 (35.88%) 
11–13 years 18 797 (39.02%) 13 334 (39.53%) 5463 (36.77%) 
>13 years 14 880 (30.89%) 11 236 (33.31%) 3644 (24.53%) 
Missing 1091 (2.21%) 672 (1.95%) 419 (2.82%) 
Postmenopausal status, N (%) 
Premenopausal 43 112 (87.52%) 30 372 (88.29%) 12 740 (85.75%) 
Postmenopausal 4612 (9.37%) 3091 (8.98%) 1523 (10.25%) 
Missing 1533 (3.11%) 939 (2.73%) 594 (4.00%) 
Oral contraceptive use, N (%) 
Never 8089 (16.42%) 5439 (15.81%) 2650 (17.84%) 
Former 34 529 (70.10%) 24 355 (70.80%) 10 174 (68.48%) 
Current 6246 (12.68%) 4402 (12.80%) 1844 (12.41%) 
Missing 395 (0.80%) 206 (0.60%) 189 (1.27%) 
Parity, N children 2 (0–3) 2 (0–3) 2 (0–3) 
Missing, N (%) 7044 (14.30%) 4676 (13.59%) 2368 (15.94%) 
Physical activity, N (%) 
1 (very low) 2079 (4.22%) 1250 (3.63%) 829 (5.58%) 
2 (low) 4992 (10.13%) 3544 (10.30%) 1448 (9.75%) 
3 (moderate) 28 007 (56.86%) 19 320 (56.16%) 8687 (58.47%) 
4 (high) 7895 (16.03%) 5874 (17.07%) 2021 (13.60%) 
5 (very high) 3950 (8.02%) 2940 (8.55%) 1010 (6.8%) 









Missing, N (%) 125 (0.25%) 49 (0.14%) 76 (0.51%) 
Alcohol intake, 
g/day 
2.27 (0–8.38) 2.41 (0–8.48) 1.97 (0–8.07) 






4.3.1.2 Follow up 
In 2002/2003 a follow-up study was initiated and women, who had responded to the 1991/1992 
questionnaire, were alive, and living in Sweden in October 2002 were contacted. Since 
1991/1992, 1,402 women were deceased, and 567 women had emigrated. 47,859 women were 
invited to participate. 34,415 women (73%) returned the questionnaire which included psychotic 
experiences using the CAPE scale. The study group which consisted of 73% of the whole cohort 
was similar to the latter with respect to age, and education, the main confounders included in the 














































4.3.2.1 Psychotic Experiences 
The Community Assessment of Psychic Experiences (CAPE) 
(http://www.cape42.homestead.com) was used to measure psychotic experiences. This is a 
modified version of the Peters et al. Delusions Inventory, which is based on the 9th edition of the 
Present State Examination(Peters, Joseph, & Garety, 1999). Our version of the CAPE 
questionnaire contained 20 questions on psychotic-like symptoms, including only the positive 
symptoms. The full 42-item CAPE has three subscales(positive, depressive and negative 
symptoms) and demonstrates satisfactory reliability, construct and discriminant validity(Brenner 
et al., 2007; Fonseca-Pedrero, Paino, Lemos-Giráldez, & Muñiz, 2012). The  20-item positive 
scale most strongly predicts future psychosis (Welham et al., 2009). The CAPE  is a stable, valid 
and reliable self-report instrument for the measurement of psychotic-like experiences in the 
general population based on cross-validation with interview-based data (Konings, Bak, Hanssen, 
van Os, & Krabbendam, 2006). The degree of distress associated with the experience was not 
included in the current study. The questions were translated from English into Swedish and back-
translated to increase fidelity to the original scale. 
Many epidemiological studies chose to group or categorise data.  As a main outcome variable in 
this study, for more efficient use of the true CAPE scale, we calculated the mean CAPE score 
















Table 4 Questions on positive psychotic-like symptoms only (Community Assessment of Psychic 









Often Sometimes Never 
1. Do you ever feel as if people seem to drop hints 
about you or say things with a double meaning? 
    
2. Do you ever feel as if things written in 
magazines or on TV are especially for you? 
    
3. Do you ever feel as if some people are not what 
they seem to be? 
    
4. Do you ever feel as if you are being persecuted 
in some way? 
    
5. Do you ever feel as if there is a conspiracy 
against you? 
    
6. Do you ever feel as if you are destined to be 
someone very important? 
    
7. Do you ever feel that you are a very special or 
unusual person? 
    
8. Do you ever think that people can communicate 
telepathically? 
    
9. Do you ever feel as if electrical devices such as 
computers can influence the way you think? 
    
10. Do you believe in the power of witchcraft, 
voodoo or the occult? 
    
11. Do you ever feel that people look at you oddly 
because of your appearance? 
    
12. Do you ever feel as if the thoughts in your head 
are being taken away from you? 
    
13. Do you ever feel as if the thoughts in your head 
are not your own? 
    
14. Have your thoughts ever been so vivid that you 
were worried other people would hear them? 
    
15. Do you ever hear your own thoughts being 
echoed back to you? 
    
16. Do you ever feel as if you are under the control 
of some force or power other than yourself? 
    
17. Do you ever hear voices when you are alone?     
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18. Do you ever hear voices talking to each other 
when you are alone? 
    
19. Do you ever feel as if a double has taken the 
place of a family member, friend, or 
acquaintance? 
    
20. Do you ever see objects, people or animals that 
other people cannot see? 





4.3.2.2 Sun Exposure 
Sun exposure was measured at baseline by the following two variables: 
HISTORY OF SUNBURN: For each 10 year age period (10–19, 20–29 and 30-39), the 
participants were asked to report the number of times per year they had been burned by the sun 
(in Sweden or on beach holiday abroad) so severely that it resulted in pain or blisters that 
subsequently peeled by choosing from among five categories: never, one time per year, two or 
three times per year, four or five times per year, or six or more times per year.    
SUNBATHING HOLIDAYS: Participants reported the average number of weeks per year spent 
on sunbathing vacations in Sweden or in southern latitudes (at this time typically southern Europe, 
e.g., Spain or Greece) for each age decade by choosing from among five categories: never, 1 
week per year, 2–3 weeks per year, 4–6 weeks per year, or ⩾ 7 weeks per year.   
For each category of sun exposure history, we combined exposure across the three decades: 
10–19 years, 20–29 years and 30-39 years. Thus, we created three categories for each sun 
exposure variable: Sunbathing holidays (Never; 1 week per year; ≥2 weeks per year) and History 
of sunburn (None; 1 time; ≥2 times).  
4.3.3 Confounders 
Lifestyle factors controlling access to sunbathing vacation and awareness of sun-protection as 
well as psychosis risk can be assumed depending on socio-economic status (SES) and age. For 
this reason we considered years spent in education and attained age (in years) as possible 
confounders in all our analyses.  
SES can be measured as univariate measure of educational attainment. It has been suggested 
that for those older than 25 years, which is the case in our cohort, educational attainment is an 
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excellent proxy measure of SES. One reason for this is that after age 25, educational attainment 
is relatively constant (those pursuing advanced degrees after age 25 are typically high achievers). 
Another reason is that educational attainment is relatively easy to measure and, unlike income, 
respondents are often willing to answer questions honestly. For the purpose of this thesis and 
based on available data, we measured educational attainment by years spent in education. 
 
4.3.4 Statistical analysis 
We calculated summary statistics to compare women with different levels of sun-exposure. We 
summarized the CAPE scale by plotting side-by-side bar segmented bar charts.  We included one 
bar for each of the 20 items of the CAPE scale. Each bar is further sub-divided in segments, one 
segment for each level of the item, where the size of each segment in the figure is proportional to 
the number of women with this response. The SAS program for this bar chart is presented below. 
 
4.3.4.1 Quantile regression  
To test and estimate the association between different levels of sun-exposure (high and none vs 
intermediate exposure) and change in the CAPE scale we fitted quantile regression(Cade & Noon, 
2003). Whereas a t-test or a linear regression can test for a change in the mean between different 
groups of exposure, quantile regression allows a comparison of the entire distribution, not only 
the mean. Similar to estimating a change in mean CAPE we estimated the change in median 
CAPE. More specifically, we estimated change in the 10th, 20th ... 90th CAPE percentile. (As a 
comment, 10 percent of the data will be found below the 10th percentile, 20 percent below the 
20th percentile etc. and the 50th percentile is usually referred to as the median). We plotted the 
difference between exposure groups at each 10th CAPE percentile allowing a visual comparison 
between women subject to different levels of sun-exposure. We fitted quantile regression for each 
of the two sun-exposure covariates, sunbathing holidays and history of sunburns, separately. All 
models also included the potential confounders, years in education and age at cohort entry. 
In a quantile regression model, in the simplest situation, the outcome needs to be a continuous 
variable, but both categorical and continuous predictors can be included. As explained in the 
methods section of this chapter, the outcome measure namely CAPE scores were converted to 
a continuous variable. Thus, there are several advantages to using quantile regression when 
comparing two exposure groups. First, using quantile regression allows us to compare the entire 
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CAPE distribution not only the mean. We hypothesized that a change in sun-exposure would 
primarily be seen in the right most tail of the CAPE distribution where the women with most 
psychotic experiences are to be found. Second, quantile regression is a technique robust against 
single gross outliers and do not rely on assumptions of the data following a particular distribution 
such as the Gaussian or the binomial. 
For both sun exposure variables the intermediate and most common sun exposure (1 week or 1 
time) were chosen as the reference category. For each sun-exposure variable and each 10th 
percentile comparing two levels of sun-exposure (high vs intermediate and none vs intermediate) 
we calculated the difference in 10th percentiles together with the two-sided 95% confidence 
intervals using bootstrap(He & Hu, 2002). The SAS program for my main analysis and data set 
development is presented in Appendix section. 
 
We also performed a set of sensitivity analyses. First, we explored the exposure in different ages 
of life by refitting the models described above, but for sun-exposure during ages 10 to 19 
(adolescence period) and ages 20 to 29 separately (adulthood period). Second, of the 49,259 
women in the cohort 1991/92, 34,402 (70%) women returned for the follow-up in 2004 when PE 
was measured. Missing values and dropouts due to a mechanism acting as a confounder between 
sun exposure and PE and a not missing at random (MAR) could potentially bias the results(Little 
& Rubin, 1987). We did not find any logical reason why this should be the case. Still, in a sensitivity 
analysis we addressed this potential problem by first comparing the covariate distribution among 
the women entering the cohort 1991 with the women returning for the follow-up. Inverse 
probability weighting (IPW) is one of several methods that can reduce this bias(Seaman & White, 
2011). In this method, complete cases are weighted by the inverse of their probability of being a 
complete case. We applied this method. 
Statistical analyses were performed using the SAS version 9.4.  
 
4.4 Results  
The population consisted of N= 34,297 women who reported data on the CAPE questionnaire in 
2004. There were women with missing values on sun-exposure N=1,252 and N=663 women with 
missing values on the confounder (years in education). When filling in the questionnaire the 
women were between 30 and 50 years old (mean=40.4, Standard Deviation =5.7). The average 
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number of years in education was 12.4 years (Minimum=0, Maximum=40; Standard Deviation 













Sun exposure N 
  
Annual cumulative 
number of weeks 
spent on sunbathing 
holidays: 
33,745     
Never  3913 41.7(5.7) 11.7(3.3) 
1 week per year 10,126 40.5(5.6) 12.4(3.0) 
≥2 weeks per year   19,706 40 (5.7) 12.6(2.9) 
History of sunburns: 33,597 
  
None  2683 41.8(5.8) 11.3(2.9) 
1 time  18,722 40.7(5.7) 12.4(3.0) 
≥2 times  12,192 39.5(5.7) 12.7(2.9) 
Note 5 All values reported as mean (SD). 







The distribution of the 20 items defining the psychotic experiences is presented in Figure 11. The 
mean response scores for each item of the CAPE scale is presented in Table 6. In the entire 
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population, the distribution of CAPE scores was mildly skewed; the mean (SD) for all subjects 
was 1.19 (0.19). In an ideal population entirely free of psychotic symptoms each of the 20 items 
in the CAPE scale should have the weight 1:20. Items related to ‘Messages from TV’, ‘Witchcraft, 
voodoo or the occult’ and ‘Odd appearance’  had average of 1.1 to 1.3; ‘Being important’, ‘Being 
special’ and  ‘Double meaning’- an average of 1.3 and 1.5 while items ‘Telepathy’ and ‘False 





Figure 11 Response frequencies (%) of CAPE (20 Items) scores amongst 34,297 population based cohort 













1-Double meaning        6-Being important                                       11-Odd appearance                  16-External control 
2-Messages from TV    7-Being special                                             12-Thought withdrawal           17-Verbal hallucination 
3-False appearance      8-Telepathy                                                   13-Thougt insertion                  18-Voices conversing 
4-Being persecuted      9-Influenced by devices                             14-Thought broadcasting        19-Capgras syndrome 
5-Conspiracy                10-Witchcraft, voodoo or the occult        15-Echoed thought                    20-Visual hallucinations 
 
 0 ‘Missing data’            
 1 ‘Never’             
 2 ‘Sometimes’             
 3 “Often”                     









Label N Mean SD 
3 False appearance 34118 1.7 0.6 
8 Telepathy 34050 1.6 0.7 
1 Double meaning 34025 1.5 0.6 
7 ’Being special’ 34111 1.5 0.6 
6 Being important 34136 1.3 0.6 
10 Witchcraft, voodoo or the 
occult 
34131 1.3 0.6 
11 Odd appearance 34182 1.2 0.4 
2 Messages from TV 34175 1.1 0.4 
4 Being persecuted 34152 1.1 0.3 
5 Conspiracy 34137 1.1 0.3 
9 Influenced by devices 34147 1.1 0.3 
12 Thought withdrawal 34178 1.1 0.3 
13 Thought insertion 34183 1.1 0.3 
14 Thought broadcasting 34186 1.1 0.3 
15 Echoed thought 34153 1.1 0.3 
16 External control 34162 1.1 0.3 
20 Visual hallucinations 34131 1.1 0.3 
17 Verbal hallucinations 34168 1 0.2 
18 Voices conversing 34163 1 0.2 
19 Capgras syndrome 34154 1 0.2 





Compared with women who reported a history of one sunburn, the women with ‘None’ or ≥2 
sunburn showed higher scores on the CAPE scale with more women in the right part of the 
distribution (Figure 12, Top panel). The psychotic experiences median (50th percentile), 80th 
percentile and 90th percentile difference for ≥2 sunburn vs 1 sunburn was estimated to 0.01 
(95%CI: 0.002-0.012), 0.02 (95%CI: 0.016-0.030) and 0.03 (95%CI: 0.019-0.037) respectively. 
The PEs for women reporting 1 sunburn vs none were higher and statistically significant at 80th 
and 90th percentile only and was estimated to 0.02 (95%CI: 0.009-0.037), 0.04 (95%CI: 0.022-
0.056) respectively. Results for all 10th percentiles are presented in Table 7. 
Similarly, compared with women exposed to 1 week of sunbathing holidays, the women with none 
or ≥2 weeks showed higher scores on CAPE scale (Figure 12, Bottom panel). The results were 
statistically significant across the entire distribution of the CAPE scale. The psychotic experiences 
median (50th percentile), 80th percentile and 90th percentile difference for ≥2  weeks vs 1 week 
of sunbathing vacation was estimated to 0.003 (95%CI: 0.009-0.006), 0.02 (95%CI: 0.012-0.026) 
and 0.03 (95%CI: 0.020-0.038) respectively. The psychotic experiences median (50th percentile), 
80th and 90th percentile difference for ‘Never’ vs ‘1 week’ of sunbathing vacation was estimated 
to 0.03 (95%CI: 0.000-0.006), 0.02 (95%CI: 0.009-0.036) and 0.02 (95%CI: 0.007-0.041) 

















Figure 12 Distribution of PEs by cumulative sun exposure (history of sunburns at age 10-39 compared to ‘1 
time’ and sunbathing holidays at age 10-39 compared to holidays ‘1 week’ (adjusted for age, education). 
 
 

















Table 7 Quantile regression estimates for PLEs by levels of history of sunburns (adjusted for age and 
education). 
 
Quantile Categories  of  
history of 
sunburns (‘1 
time’ as a 
comparison 
group) 






0.1 None 0 0 0 0.0006 
0.1 ≥2 times 0 0 0 0.0008 
0.2 None 0 0 0 0.0002 
0.2 ≥2 times 0 0 0 0.0012 
0.3 None -0.0016 -0.0132 0.0101 0.7923 
0.3 ≥2 times 0.0063 0.0035 0.009 <.0001 
0.4 None -0.0008 -0.0056 0.0041 0.7522 
0.4 ≥2 times 0.0078 0.0045 0.0112 <.0001 
0.5 None 0.0011 -0.0039 0.006 0.6643 
0.5 ≥2 times 0.0072 0.0019 0.0124 0.0079 
0.6 None 0.0026 -0.0074 0.0125 0.6147 
0.6 ≥2 times 0.0137 0.0087 0.0187 <.0001 
0.7 None 0.0099 -0.002 0.0218 0.1035 
0.7 ≥2 times 0.0172 0.0119 0.0225 <.0001 
0.8 None 0.0231 0.0091 0.0371 0.0012 
0.8 ≥2 times 0.0231 0.0159 0.0302 <.0001 
0.9 None 0.0394 0.0228 0.056 <.0001 









Table 8 Quantile regression estimates for PEs by levels of sunbathing holidays (adjusted for age and 
education). 
 
Quantile Categories of 
sun exposure 
(‘1 week’ as a 
comparison 
group) 







0.1 Never 0 0 0 0.001 
0.1 ≥2  weeks 0 0 0 0.0035 
0.2 Never 0 0 0 0.0012 
0.2 ≥2  weeks 0 0 0 0.0044 
0.3 Never 0.0092 0.0044 0.0141 0.0002 
0.3 ≥2  weeks 0.0059 0.0021 0.0096 0.002 
0.4 Never 0.0085 0.0037 0.0134 0.0006 
0.4 ≥2  weeks 0.0053 0.0024 0.0082 0.0003 
0.5 Never 0.0034 0.0001 0.0067 0.0428 
0.5 ≥2  weeks 0.0034 0.0009 0.0059 0.0078 
0.6 Never 0.0167 0.0091 0.0242 <.0001 
0.6 ≥2  weeks 0.0133 0.0087 0.018 <.0001 
0.7 Never 0.0173 0.0084 0.0261 0.0001 
0.7 ≥2  weeks 0.0148 0.0094 0.0202 <.0001 
0.8 Never 0.0231 0.0094 0.0368 0.001 
0.8 ≥2  weeks 0.0192 0.0118 0.0267 <.0001 
0.9 Never 0.0244 0.0071 0.0417 0.0056 










The results were comparable when restricting the analyses to sun exposure at specific age 
periods; ages 10-19 and ages 20-39 (Figure 13 and Figure 14).  
 
Figure 13 Distribution of PEs by levels of sun exposure at age 10-19 (history of sunburns at age 10-19 















Figure 14 Distribution of PEs by sun exposure at age 20-39 (history of sunburns at age 20-39 compared to 

















I predicted probabilities of participating in the follow up part of the study based on subject 
characteristics. After applying the weights to the quantile regression models, we concluded that 
the estimates did not differ from the original estimates (Figure 15). 
 
Figure 15 Distribution of PEs by levels of sun exposure at age 20-39 (history of sunburns at age 20-39 
compared to ‘1 time’ and sunbathing holidays at age 20-39 compared to holidays ‘1 week’ (after applying 












In the Nordic countries, as elsewhere, sun exposure is by far the most important source of vitamin 
D. In a population based cohort of 34,402 women we found an association between cumulative 
measures of sun exposure at ages 10 to 39 years and positive psychotic experiences. We 
observed a U-shaped association where women with low sun exposure as well as women with 
high sun exposure reported more psychotic experiences compared to women with an 
intermediate level of sun exposure.  
The U-shaped association is consistent with previous studies on vitamin D and health outcomes 
(J. J. McGrath, Eyles, et al., 2010) which reported a 2-fold increased risk of schizophrenia in those 
in the lower quartile compared to those in the fourth quartile Additionally, those in the highest 
quartile of vitamin D levels had a statistically significant increased risk of schizophrenia compared 
with those in the fourth quintile.  
The non-linearity in the association might argue against a possible causal relationship. However, 
the associations with sun exposure and health outcomes are often non-linear with advantageous 
effects of a balanced exposure (WHO, n.d.). 
An earlier study using the same cohort of women as in this study showed that vitamin D intake 
from the diet was statistically significantly associated with a decreased relative risk of both 
medium and high levels of psychotic symptoms (Hedelin et al., 2010). The present study 
examined the sun exposure variables considering sun exposure as a main source for vitamin D 
levels  and not diet (Holick, 2004; LeBlanc et al., 2014; Umhau et al., 2013). Additionally, in the 
present study I used the entire CAPE scale instead of categorizing the responses which might 
exclude important information.  
Consequently, a major strength of my study is the detailed assessment of sun exposure during 
different periods of life. The information on sun exposure habits was gathered at the start of the 
study which minimizes the risk of reverse causality. This study possibly includes non-differential 
(or random) measurement as sun exposure information was collected retrospectively. This might 
attenuate examined associations. Such measurement error could under-estimate the true 
association. 
Another major strength of this study is use of an unselected large population-based cohort drawn 
from the Swedish National Population Register and followed for over 10 years.  
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In the present study I performed a quantile regression, an approach particularly suitable for 
epidemiologists, since scientific interest is often on high or low, e.g.(Hedelin et al., 2010) – rather 
than average – degrees of response. This approach is particularly important when assessing a 
risk factor that does not have a linear relationship. From a public health and nutrition policy 
perspective, specific areas of the outcome distribution are likely to be of more interest than others. 
For example, instead of focusing on the mean of the dependent variable, scientists could explore 
characteristics (individual, social, environmental) that are associated with this variable, which are 
of concern once they are linked to chronic diseases. These associations are subject to exploration 
even when the mean of the dependent variable is not significantly associated with a set of 
covariates (Cade & Noon, 2003). 
Our study has several limitations. We had no biological data on vitamin D levels, which could 
have established a clear link to vitamin D and yet it is well known that sun exposure is the most 
important determinant of vitamin D status (Holick, 2004; LeBlanc et al., 2014). Additionally, the 
assumption was made that sun exposure habits did not change over time and consequently, 
information from one assessment alone was used in the models. This is a common assumption 
in cohort studies and tends to underestimate risk. However, the questionnaire took into 
consideration changes, as it asked about exposure in different decades.  
The current study was based on multiple exposure factors (several sun exposure variables) as 
proxies for vitamin D level and their relationship with psychotic experiences. The estimates were 
adjusted for confounding effects and each exposure variable was assessed independently in 
order to detect any potential effect. Still, our results should be interpreted cautiously. Even well-
designed observational studies can be influenced by residual confounding. There may also be a 
number of unknown factors that we did not take into consideration in our study, which could 
influence psychotic experiences and be related to sun exposure. 
We did not have data on the full CAPE scale, but only the positive symptoms. Moreover, the 
degree of distress associated with psychotic experiences was not included in the current study, 
which could have allowed a more detailed analysis on items and dimensions. The CAPE scale of 
psychotic experiences are correlated with measures of general psychopathology, including 
depression. The association between the positive and the depressive dimension in CAPE, which 
we could not include for practical reasons, is fairly low when distress associated with positive 
symptoms is held constant (r = 0.25)  (Stefanis et al., 2002). As a consequence, the dimension of 
positive symptoms are believed to be considered an independent dimension. Further, data on 
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psychotic experiences were not measured at baseline therefore reverse causality could be a 
potential explanation of findings. 
In terms of generalizability of the present study, males were not included and previous reports 
suggest a gender difference in the incidence of psychosis. However, in general population 
samples, psychotic experiences are found to be equally distributed among males and 
females(Peters et al., 1999)(Varghese, Scott, & McGrath, 2008). 
4.5.1 CONCLUSION 
Both low and high sun exposure is associated with increased levels of psychotic experiences. 
Previous studies have reported associations between vitamin D and increased risk for health 
problems, such as schizophrenia, as well as clinical symptoms in patients with mental health 
problems. However, there is a lack of previous studies on how sun exposure, the main source of 
vitamin D, influences psychotic experiences in the general population. This study's contribution 
to the literature is that in the general population of Swedish women sun exposure has a U-shaped 



















Chapter 5 Sun Exposure, Vitamin D and Depressive Symptoms 
5.1 Summary  
UV exposure is the most important source of vitamin D. Vitamin D deficiency has been suggested 
to play a role in the aetiology of mood disorders. The aim of the present study was to examine 
the association between sun exposure behaviours and depressive symptoms in a general 
population sample of Swedish women.  The study population included participants from The 
Swedish Women's Lifestyle and Health cohort study. A questionnaire (based on DSM IV criteria 
for depression) was administered to study participants between ages 30 and 50 to establish 
depressive symptoms. Sun exposure as measured by 1) sunbathing holidays and 2) history of 
sunburn was measured between ages 10 to 39. The association between sun exposure and 
depressive symptoms was evaluated by logistic regression models. 34 010 women were included 
in the analysis. Women who reported a history of two or more sunburns showed positive 
association with depressive symptoms, compared to history of a single sunburn, when adjusting 
for age and education. The same association was not evident for sunbathing holidays and 
depressive symptoms. The findings of this study suggest that in a population based cohort of 




Mental health problems, including depression, are major contributors to health morbidity and 
mortality worldwide. Depressive symptoms were previously reported in a general population and 
one study showed that of the nine symptoms assessed, the most frequently occurring were 
dysphoric mood, increased sleep, and loss of interest in other people or activities previously 
enjoyed (Henderson & Pollard, 1992). The findings provide evidence that various symptoms of 
depression may be more common in the general population than previously suspected 
(Henderson & Pollard, 1992).  
Insufficient sun exposure and vitamin D deficiency have both been associated with increased risk 
of depression. A UK based prospective study of children (ALSPAC) found higher concentrations 
of season-adjusted 25(OH)D3 assessed at mean age 9.8 years to be associated with lower levels 
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of depressive symptoms at age 13.8 years and with increased odds of decreasing symptoms 
between age 10.6 and 13.8 years (A.-M. Tolppanen et al., 2012).  
In a recent Meta-Analysis vitamin D deficiency has been documented in patients with depression 
(Anglin et al., 2013). Considering the high prevalence of both vitamin D deficiency and depression, 
an association between these two conditions would have significant public health implications. 
The observational studies to date provide some evidence for a relationship (Kerr et al., 2015; 
Wilkins, Sheline, Roe, Birge, & Morris, 2006), but there is no evidence for an association between 
vitamin D from sun exposure and depressive symptoms in the general population. Because 
depressive symptoms are common and associated with a range of adverse health outcomes 
(Black, Markides, & Ray, 2003; Del Pozo-Cruz et al., 2015; Doğan, Onat, Kaya, Ayhan, & Can, 
2011) it is important to study them. Moreover, since individuals with depressive symptoms 
generally do not receive anti-depressive medications potential confounding by medication is 
avoided.  
The biological mechanism whereby vitamin D might be associated with psychiatric illnesses is not 
well understood. Vitamin D is an essential nutrient that plays an important role in many 
biochemical functions that contribute to ageing, including bone renewal, cell proliferation, 
hormone balance, and cardiovascular and glucose metabolism (Berridge, 2015). Of particular 
interest is accumulating evidence for the actions of vitamin D in the brain (Cui et al., 2014; D. 
Eyles et al., 2003; Holick & Chen, 2008). Vitamin D is involved in the synthesis of serotonin and 
dopamine within the brain, both chemicals linked to depression. Evidence now links low vitamin 
D levels with reduced cognitive performance (Annweiler et al., 2010; Wilkins et al., 2006), 
increased risk for cancer, diabetes, cardiovascular disease, and death (Grant et al., 2015; 
LeBlanc et al., 2014; Pludowski et al., 2013). It has been reported that there are vitamin D 
receptors in the hypothalamus and there is an interactions between vitamin D receptors and 
glucocorticoid receptors in the hippocampus. Depression has been associated with immune 
abnormalities (Yirmiya, 2000);hippocampal and glucocorticoids abnormalities. Taken together, 
evidence suggests that vitamin D might play a role in psychiatric illness such as depression (Berk 
et al., 2007; Black et al., 2003; Jorde, Sneve, Figenschau, Svartberg, & Waterloo, 2008; 
Penckofer, Kouba, Byrn, & Estwing Ferrans, 2010) .  
The main source of vitamin D for humans is from its dermal synthesis by exposure  to sunlight 
(Lips et al., 2014; Touvier et al., 2015) which provides up to 90% in the form of  vitamin D3 
(cholecalciferol) with the remainder coming from food in the form of vitamin D3 or vitamin D2 
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(ergocalciferol) (Holick, 2004; Holick & Chen, 2008; LeBlanc et al., 2014; Umhau et al., 2013).  
Solar ultraviolet B radiation with a wavelength between 290 and 315 nm, penetrates the skin and 
converts 7-dehydrocholesterol to pre-vitamin D3, which then is isomerized by heat to vitamin D3 
before being carried, bound to vitamin D binding protein, to the liver where it is converted into the 
main metabolite 25-hydroxyvitamin D3. Prolonged sun exposure does not result in the production 
of excess quantities of vitamin D3 to cause intoxication. Moreover, it has been argued that 
prolonged exposure can break down vitamin D, reducing health benefits and increasing risk of 
skin cancer (Annweiler et al., 2010; Berridge, 2015). Therefore, it has been suggested that 
moderate sun exposure is as effective as long sun exposure for previtamin D production 
(Annweiler et al., 2010; Cui et al., 2014) 
While there is sufficient evidence of an association between low serum 25(OH)D and mood 
disorders such as depression (Bertone-Johnson et al., 2011; Jorde et al., 2008; Kerr et al., 2015), 
there is still a lack of studies on sun exposure, the main source of vitamin D in most countries. 
Given the limited research, the aim of this study is to investigate the association between past 
and recent sun exposure sun exposure (as a proxy for vitamin D status) and later depressive 
symptoms. Using a large, prospective, population based, cohort study, we tested the hypothesis 
that sun exposure behaviour predicts later depressive symptoms. 
 
5.3 Methods 
5.4 Measures  
5.4.1 Assessment of Depressive Symptoms by a self-report questionnaire.  
Depressive symptoms were assessed in this cohort with the reliable screening assessment for 
depression based on the DSM-5 criteria (American Psychiatric Association, 2013). Current 
National Institute for Health and Care Excellence (NICE) guidance uses the Diagnostic and 
Statistical Manual Fourth Edition (DSM-V) classification (https://www.nice.org.uk/guidance/cg90 
). According to the guideline, to diagnose major depression, this requires at least one of the 
core symptoms: 
1) Persistent sadness or low mood nearly every day. 
2) Loss of interests or pleasure in most activities. 
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The corresponding 2 questions were included in a self-report questionnaire assessing 
participants’ attitude and feelings. Questions were answered with “Yes” or “No”. 
1-Have you ever felt sad, down or depressed two weeks or longer in a row?  
2-Has there ever been a time period which has lasted two weeks or more, when you’ve lost all 
interest in most things in life, such as work, hobbies or some other occupation you usually enjoy?  
The questions were translated from English into Swedish and back-translated to increase 
reliability to the original scale.  
We considered the above two questions as two main outcomes of depressive symptoms. Both 
outcome variables are binary (Yes/No). Only women with non-missing data were included.  
 
5.4.2 Sun Exposure 
Sun exposure was measured by the following two variables: 
HISTORY OF SUNBURN: For each 10 year age period (10–19, 20–29 and 30-39), the 
participants were asked to report the number of times per year they had been burned by the sun 
so severely that it resulted in pain or blisters that subsequently peeled by choosing from among 
five categories: never, one time per year, two or three times per year, four or five times per year, 
or six or more times per year.    
SUNBATHING HOLIDAYS: Participants reported the average number of weeks per year spent 
on sunbathing vacations in Sweden or in southern latitudes (at this time typically southern Europe, 
e.g., Spain or Greece) or Sweden for each 10 year age period by choosing from among five 
categories: never, 1 week per year, 2–3 weeks per year, 4–6 weeks per year, or ⩾7 weeks per 
year.   
For each category of sun exposure history, we combined exposure across the three decades: 
10–19 years, 20–29 years and 30-39 years. Thus, we created three categories for each sun 
exposure variable: Sunbathing holidays (Never; 1 week per year; ≥2 wks per year) and History of 
sunburn (None; 1 time; ≥2 times).  
5.5 Confounders 
Similarly to the previous study, lifestyle factors controlling access to sunbathing vacation and 
awareness of sun-protection as well as depression risk can be assumed depending on socio-
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economic status and age. For this reason we considered years spent in education and attained 
age (in years) as possible confounders in all our analyses.  
5.6 Statistical Analysis 
We calculated summary statistics to compare women with different levels of sun-exposure on 
baseline characteristics (age and education, both continues variables). We summarized the 
outcome variables related to depressive symptoms by plotting side-by-side bar segmented bar 
charts (two separated bar charts for each outcome).  Each segment represents the level of the 
item (1=Yes and 2=No), the size of each segment in the figure is proportional to the number of 
women with this response. 
5.6.1 Logit regression  
Logistic regression, or a logit model, is used to model dichotomous outcome variables. In the logit 
model the log odds of the outcome is modelled as a linear combination of the predictor 
variables.  A logistic regression model describes a linear relationship between the logit, which is the 
log of odds, and a set of predictors. 
 
Logit (π) = log (π/ (1-π)) = α + β1*x1 + + ... + βk*xk = α + x β 
 
The association between sun exposure (sunbathing holidays and history of sunburns) and 
depressive symptoms (“Feeling unusually sad or down in the dumps” and “Lost interest in most 
things or activities once enjoyed”) was summarised in terms of odd ratios (ORs) and 
corresponding 95% confidence intervals, and it was evaluated by age and education adjusted 
binary logistic regression using LOGISTIC procedure to model the analyses in SAS program 
version 9.4. For both sun exposure variables the intermediate and most common sun exposure 
(‘1 week’ for sunbathing holidays and or ‘1 time’ for history of sunburns) were chosen as the 
reference category. The estimated associations given by a logistic regression are odd ratios (OR). 
Since the outcome status (namely depressive symptoms) among participants was unknown at 
study entry we cannot draw any conclusions about causality but only about the existence of 
associations (negative or positive). Based on the hypothesis under study we interpreted the OR<1 
as a negative association and OR>1 as a positive association. 
Missing values and dropouts due to a mechanism acting as a confounder between sun exposure 
and depressive symptoms and a not missing at random (MAR) could potentially bias the 
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results(Little & Rubin, 1987). We did not find any logical reason why this should be the case. Still, 
in a sensitivity analysis we addressed this potential problem by first comparing the covariate 
distribution among the women entering the cohort 1991 with the women returning for the follow-
up. Inverse probability weighting (IPW) is one of several methods that can reduce this 
bias(Seaman & White, 2011). In this method, complete cases are weighted by the inverse of their 
probability of being a complete case. We applied this method. 
Models adjusted for potential confounders, including education and age at baseline were fitted. 
Statistical analyses were performed using the SAS version 9.4 
 
5.7 Results 
Among the 34 415 women included in the study, we had information on depressive symptoms for 
34, 402 women (follow-up study). Participants with missing data on depressive symptoms were 
excluded from the analysis (n = 392). Thus, a total of 34, 010 women were included in the 
analysis. 
Of 34, 010 Swedish women included in the analysis 16, 135 women (47%) responded positively 
to “Feeling unusually sad or down in the dumps”. Additionally, of 34, 010 women 12, 447 (37%) 
responded positively to the second question assessing depressive symptoms (“Lost interest in 
most things or activities once enjoyed”).  
 
Baseline characteristics by the two predictor variables with three level group of sun exposure are 























Annual cumulative number of 




Never  3,894 41.7(5.7) 11.7(3.3) 
1 per week  10,043 40.5(5.6) 12.4(3.0) 
≥2 per week   19,544 40 (5.7) 12.6(2.9) 
History of sunburns: 33,334 
  
None  2,652 41.8(5.8) 11.3(2.9) 
1 time  18,593 40.6(5.7) 12.4(3.0) 
≥2 times  12,089 39.5(5.7) 12.7(2.9) 
 
Note 8 All values reported as mean (M) and Standard Deviation (SD). 


















When filling in the questionnaire the women were between 30 and 50 years old (mean=40.4, 
Standard Deviation =5.7). The average number of years in education was 12.4 years 
(Minimum=0, Maximum=40; Standard Deviation =3.0).  
Table 10 shows results of a logistic regression analysis for the association of depressive 
symptoms and sun exposure measures. The first model is a crude logistic univariate relationship 
of sun exposure (history of sunburns and sunbathing holidays) and depressive symptoms 
(“Feeling unusually sad or down in the dumps” and “Lost interest in most things or activities once 
enjoyed”). The results showed that having been sunburned more than twice a year, versus one 
time, increases the log odds of having depressive symptoms (“Feeling unusually sad or down in 
the dumps”) by  1.23 (95%CI 1.17-1.28). For women reporting no history of sunburns versus one 
sunburn the association was inversed with depressive symptoms at OR being 0.84 (95%CI 0.77- 
0.91). In Model 2, age at baseline and years in education were added to the previous model. The 
adjusted model retained its independent significant OR for reporting history of sunburns more 
than twice a year, versus one time OR 1.22 (95%CI 1.16-1.27). The results revealed no 
statistically significant association between the sunbathing holidays and “feeling unusually sad or 
down in the dumps”.    
Similarly, history of sunburns (>=2 times vs 1 time) was significantly associated with depressive 
symptoms (“Lost interest in most things or activities once enjoyed”) in unadjusted and adjusted 
models with OR being 1.17 (95%CI 1.11-1.22) and 1.14 (95% CI 1.09-1.19) respectively. 
Sunbathing holidays (>=2 weeks vs 1 week) was statistically significantly associated with “Lost 
interest in most things or activities once enjoyed” only in model 1, OR being 1.06 (95%CI 1.006 
to 1.11), and at borderline significance after adjusting for age and education status (OR 1.050, 











Table 10 Logistic Regression Analysis for the Association of Sun Exposure Variables with Two Outcomes 
Measures of Depressive Symptoms. 
 
 
“Feeling unusually sad or down in the dumps” 
  
















History of sunburns 
 
(>=2 times vs 1 time) 1.231 1.176         1.289 
 
1.216  1.161         1.274 
(None vs 1 time) 0.844 0.777         0.917 0.891 0.819         0.969 
 




(>=2 weeks vs 1 week) 1.043 0.994         1.095 1.041 0.991         1.093 
(Never vs 1 week) 0.931 0.865         1.003 0.978 0.907         1.055 
 
“Lost interest in most things or activities once enjoyed” 
 
History of sunburn  
(>=2 times vs 1 time) 1.167 1.113 1.223 1.143 1.090         1.199 
(None vs 1 time) 0.946 0.868 1.030 0.975 0.893         1.064 
 
Sunbathing Holidays:  
     
(>=2 weeks vs 1week) 1.058 1.006  1.112 1.050 0.998         1.105 
(Never vs 1 week) 1.028 0.952  1.110 1.073 0.993         1.161 
 
Note 9 Only the ORs in bold are of statistical significance. 
OR = Odd ratios 
Model 1 = Unadjusted  







We predicted probabilities of participating in the follow up part of the study based on subject 
characteristics. After applying the weights to the logit regression models, we concluded that the 
estimates did not differ from the original estimates 
5.8 Discussion 
Sun exposure is the most important source of vitamin D. In a population based cohort of 34,010 
women we found that history of multiple sunburns was associated with depressive symptoms. It 
is worth noting the prevalence of depressive symptoms in this sample (47% and 37% responding 
positively) is relatively high.  
The results revealed an association between multiple sunburns and depressive symptoms 
however the same association is not evident for sunbathing holidays and depressive symptoms. 
Further, no sun exposure is not associated with depressive symptoms. Biologically, the sunburns 
caused by exposure to UV radiation should produce vitamin D.  However, the extensive exposure 
to UV could produce too much vitamin D which might induce negative health outcomes (more 
depressive symptoms).  In fact, exposures to the sun can break down vitamin D and reduce health 
benefits, for example according to our study the overexposure could increase depressive 
symptoms. Alternatively, women who experienced multiple sunburns after UV exposure might 
exhibit a tendency to more risky behaviour. Although this association is evident in this population, 
the reasons why the women with more depressive symptoms would experience more sunburns 
compared with the rest of the population are unclear. Else, the observed association might 
represent self-medication— i.e. sun exposure produces vitamin D thus could improve the mood 
and provide many positive health outcomes or simply relieves boredom or distress (an 
assumption of the more sunshine the more vitamin D and enhanced health benefits) which could, 
in fact, indicate reverse causality.  
No earlier studies that we are aware of have evaluated the relationship between different life 
periods sun exposure and vitamin D levels and depressive symptoms. The findings from my study 
contradicts previous work on sun exposure, vitamin D and health outcomes. For instance, one 
study found that there was no close association of vitamin D levels with depression (Knippenberg 
et al., 2014). Interestingly, when sun exposure was taken into account, this association was no 
longer statistically significant indicating that sun exposure has a more potent effect on depression 
which is independent of vitamin D synthesis (Knippenberg et al., 2014). Another study by Wilkins 
et al 2006 examined the relationship between vitamin D status, cognitive performance, mood, and 
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physical performance in older adults. Their findings showed that vitamin D deficiency was 
associated with low mood and with impairment on some measures of cognitive performance 
(Wilkins et al., 2006). 
The present study examined the sun exposure variables considering sun exposure as a main 
source for vitamin D levels  and not diet (Holick, 2004; LeBlanc et al., 2014; Umhau et al., 2013). 
In terms of confounding variables we controlled for age at baseline and years spent in education. 
Studies showed that these are the main demographic variables associated with depressive 
symptoms in a general population (Henderson & Pollard, 1992).  
Consequently, a major strength of our study is the detailed assessment of sun exposure during 
different periods of life. The information on sun exposure habits was gathered at the start of the 
study which minimizes the risk of reverse causality. Another major strength of this study is use of 
an unselected large population-based cohort drawn from the Swedish National Population 
Register and followed for over 10 years. 
As explained above, this study found the opposite link to what was expected. However, there are 
many important limitations to this study. This includes the possibility that other health and lifestyle 
factors are influencing the link. 
The results of this study must be interpreted in light of limitations associated with a structured 
interview and the potential for participants’ response bias. The questionnaire-based assessment 
of sun exposure was possibly prone to measurement error. Also, data on sun exposure was 
collected retrospectively. Recall bias might result in either an underestimate or overestimate of 
the association between sun exposure and the outcome. However, the recall bias (if present) 
should not have a differential effect (i.e., those with more psychotic symptoms remember more 
exposure and those without psychotic symptoms remember less) on the study, and therefore, 
results should not be systematically biased.  
Further, we had no biological data on vitamin D levels, which could have established a clear link 
to vitamin D and yet it is well known that sun exposure is the most important determinant of vitamin 
D status (Holick, 2004; LeBlanc et al., 2014). Additionally, the assumption was made that sun 
exposure habits did not change over time and consequently, information from one assessment 
alone was used in the models. This is a common assumption in cohort studies and tends to 
underestimate risk. However, the questionnaire took into consideration changes, as it asked 
about exposure in different decades.  
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The current study was based on multiple exposure factors (several sun exposure variables) as 
proxies for vitamin D level and their relationship with depressive symptoms. The estimates were 
adjusted for confounding effects and each exposure variable was assessed independently in 
order to detect any potential effect. Still, our results should be interpreted cautiously. Even well-
designed observational studies can be influenced by residual confounding. There may also be a 
number of unknown factors that we did not take into consideration in our study, which could 
influence depressive symptoms and be related to sun exposure. 
Moreover the assessment of depressive symptoms included only two questions however the 
questions were based on the diagnostic criteria DSM-5. This form of assessment of depressive 
symptoms in the general population was not previously validated in this cohort  
In terms of generalizability of the study, males were not included. Previous research showed that 
female gender was significantly associated with depressive symptoms (Doğan et al., 2011; Ford 
& Erlinger, 2004). The study showed that prevalence of a major lifetime depression among 6914 
young US adults from the NHANES-III survey was higher for women than men (5.7% in men and 
11.7% in women). Epidemiological findings point to a female gender in prevalence of depressive 
symptoms (Piccinelli, 2000). 
 
5.8.1 CONCLUSION 
High sun exposure (history of sunburns) vs intermediate exposure is associated with some 
symptoms of depression, in particular with feeling sad or depressed and lost interest in most 
things or activities once enjoyed. Previous studies have reported relationships of vitamin D with 
increased risk for health problems, such as depression, as well as clinical symptoms in patients 
with mental health problems. However, there is a lack of previous studies on how sun exposure, 
the main source of vitamin D, influences depressive symptoms in the general population. This 
study's contribution to the literature is that in the general population of middle-aged Swedish 









Chapter 6 General Discussion  
This section will summarize and integrate the findings from the studies presented in chapter 3-5. 
While above evidence and other data suggest  PUFA  and/or vitamin D imbalance may be a risk 
factor for schizophrenia, depression and cognitive decline, their role in the onset of psychotic or 
depressive symptoms remain uncertain and their biological mechanism are not well understood. 
Further investigations of a possible relationship between nutrients status in cognitive 
development, psychotic and depressive symptoms is required. Indeed psychiatric conditions and 
cognitive disturbances involve so much more than PUFA or vitamin D imbalance yet there is some 
evidence for these nutrients being related to cognitive impairments and mental health. There is 
no definitive approach to examine nutrition and its effect on neurodevelopment or late mental 
health therefore the assessment could only take place through lifespan examination.  
 
This thesis has the following specific aims:  
1) Determine the association between prenatal fish oil intake and the offspring cognitive 
abilities with focus on general and specific cognitive abilities using a Meta-Analysis approach 
2) Examine if there is an association between UV exposure, vitamin D and psychotic 
experiences in adult Swedish women 
3) Determine if there is an association between UV exposure, vitamin D and depressive 
symptoms in the adult Swedish women.  
 
Aim 1 was examined using a Meta-Analysis; data for Aims 2 and 3 comes from the Women 












6.1 Summary of findings  
 
6.1.1 Fish Oil and Fish Intake during Pregnancy and Cognitive Functioning In Offspring: 
Systematic Review and Meta-Analysis of Randomised Control Trials and Observational 
Studies 
 
In the first study, I demonstrated that that prenatal fish oil or fish intake was associated with better 
cognitive abilities in the offspring. I found concordance across reviewed study designs where 
randomised control trials supported the results of the observational studies on this topic. 
Evaluations of eight randomized control trials found the results approaching statistical significance 
towards better cognitive functions among children of mothers in fish oil intervention group.  
Examination of specific cognitive outcome showed that fish oil was particularly beneficial for 
memory functions. Analyses of observational studies suggest that consuming fish 2-3 times a 
week, which was the most common category of fish consumption by pregnant women in the 
selected studies, is beneficial for optimal cognitive development of the offspring specifically for 
domains related to language and verbal skills. 
 
 
6.1.2 Sun Exposure, Vitamin D and Psychotic Experiences 
 
The results from this study showed that, in the Nordic countries, as elsewhere, where sun 
exposure is the most important source of vitamin D, in a population based cohort of 34,402 
women, there was an association between cumulative measures of sun exposure (sunbathing 
holidays and history of sunburns)  at ages 10 to 39 years and positive psychotic experiences. I 
observed a U-shaped association where women with low sun exposure as well as women with 
high sun exposure reported more psychotic experiences compared to women with an 






6.1.3 Sun Exposure, Vitamin D and Depressive Symptoms 
 
Unexpectedly, the findings from this study revealed that cumulative measures of sun exposure 
(history of multiple sunburns)  at ages 10 to 39 years was associated with some depressive 
symptoms in the population of adult Swedish women. In this study a high proportion of women 
reported depressive symptoms described as feeling unusually sad or lost interest in most things, 
or activities once enjoyed. 
 
 
6.2 Strengths and limitations 
6.2.1 Strengths 
The key strength of this thesis is the evaluation of nutrients across lifespan (from pregnancy to 
adulthood). Starting with the Meta-Analysis, by combining studies, any Meta-Analysis increased 
the sample size and thus the power to study effects of interest. Some research suggest that meta-
analyses should be conducted only on randomized controlled trials as meta-analyses should 
include only reasonably well-conducted studies to reduce the risk of a misleading conclusion. 
However, many important conditions can only be studied observationally. The Comprehensive 
Meta-Analysis and systematic review methods allowed me to compare the effects from 
randomised control trials and observational studies and strengthen the conclusion of prenatal fish 
oil and fish intake as potential enhancement for the offspring cognitive abilities. Another strength 
of this study is the fact that the study examined specific and overall cognitive domains and 
therefore methodically evaluated a complete neuropsychological profile in the offspring of 
mothers supplemented with fish oil or those who consumed fatty fish enriched in omega-3.  
Further, strengths of the studies related to the UV exposure and mental health outcomes include 
the access to high quality data, its large size, prospective design, and virtually complete follow-
up through linkages to national registries. The large sample size of over 30 000 women provides 
the statistical power to investigate the outcomes. The information on UV exposure at different 
periods in life and relevant data on host characteristics and lifestyle factors is also an important 
strength. The Women Lifestyle and Health study contain detailed information on individual 
characteristics important in our analyses. The data in longitudinal cohort designs is normally 
collected for reasons independent of both the exposure variables (sun exposure) and the outcome 
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variables (psychotic experiences and depressive symptoms). A main strength of the cohort is that 
follow-up of the women is based on the unique national registration number, allowing linkage to 
a broad range of validated Swedish registries that include information on things such as cause 
and date of death, hospital discharge and drug use. Reporting is mandatory for several of these 
registries and, as mentioned previously, the validity of Swedish registries has generally been 
found to be high (Barlow, Westergren, Holmberg, & Talbäck, 2009; Roswall et al., 2015).  
The information include confounders such as age, education, alcohol intake and important 
information related to sun sensitivity characteristics which I explored in sensitivity analysis. This 
has allowed me to perform our analyses with detailed adjustments for possible confounders.  
Further, the ethnic homogeneity of our study population reduces the risk of confounding by 
unmeasured factors, both genetic and environmental.  
Additional study’s strength was a detailed assessment of sun exposure between age 10-39 
including both sun exposures in southern latitude and in Sweden. A strong association between 
the UV exposure questionnaire and risk of malignant melanoma shown in previous analyses from 
the same cohort (Yang et al., 2011) suggested that those questions assessing sun exposure are 
appropriate.  
No earlier studies that we are aware of have evaluated the relationship between sun exposure, 
vitamin D and psychotic symptoms in adult life. The present study examined the sun exposure 
variables considering sun exposure as a main source for vitamin D levels and not diet. Sunlight 
is the superior source for vitamin D, as when you expose your skin to sunshine, your skin 
synthesizes vitamin D3 sulphate. This form of vitamin D is water soluble, unlike oral vitamin D3 
supplements, which is unsulphated. The water-soluble form can travel freely in your bloodstream, 
whereas the unsulphated form needs LDL (the so-called "bad" cholesterol) as a vehicle of 
transport.(Mercola, 2011). The oral non-sulphated form of vitamin D may not provide all of the 
same benefits as the vitamin D created in your skin from sun exposure, because it cannot be 
converted to vitamin D sulphate.  
We have utilised appropriate modern statistical methods. These include the use of 
Comprehensive Meta-Analysis. Meta-Analysis itself can address possible power issues in under-
powered studies. We used advanced epidemiological and statistical methods; data was 
manipulated in SAS program and the use of a quantile regression allowed to examine the 
functional form of continues variable (psychotic symptoms). Statistical methods are however not 
an independent component in epidemiological research but a bidirectional process: high quality 
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data supports the use of advanced statistical methods, and knowledge of statistical methods is a 
key when deciding what data to use.  
 
6.2.2 Limitations 
The presented studies do have some limitations. My Meta-Analysis integrated studies that used 
various cognitive tests, assessment were made at different age the randomised control trials 
varied in terms of the dosage. However I performed a meta-regression of DHA dosage in 
randomised control trials and did not find statistically significant results. Further, a meta-
regression of the effect of ‘age at assessment’ on cognitive abilities revealed no statistically 
significant moderating effect. 
Overall, the Women Lifestyle and Health cohort is limited by the potential healthy volunteer bias, 
as those with a serious illness or disability might be less likely to participate both at baseline and 
at follow-up. As explained in the description of the cohort (Roswall et al., 2015) the healthy 
volunteer bias is stronger in the selection of women who responded to the follow-up questionnaire. 
This can contribute to the generalizability of findings from the WLH study. All information collected 
in the questionnaires is self-reported, and information about the exposure and the outcomes of 
the present study is self-measured, leaving room for potential information bias. However, no 
validation studies have been conducted on information collected in the sun exposure and mental 
health questionnaires and this should be kept in mind when interpreting these data. Further, data 
on sun exposure was collected retrospectively, and recall of events from a few decades back 
could be biased.  
Our results of a protective effect of the sunshine and vitamin D in association with psychotic 
experiences must be considered as rough, since we only measure the cumulative sun exposure 
as a proxy for vitamin D. A more complete picture of the vitamin D status could have been supplied 
through vitamin D levels in blood; however, biological samples are not available.  
One of the limitations of this thesis is that in the study on sun exposure and psychotic experiences 
we have no baseline measures of symptom levels to further reveal causality between different 
levels of sun exposure and the association with positive psychotic symptoms. However, 
considering the prevalence results for psychotic disorders, fairly small number of participants in 
the population sample are likely to have a psychotic disorder, which might increase the problem 
of reversed causality related to psychotic diagnosis or medication.  
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In the studies looking at the UV exposure and mental health outcomes we had no information 
about socioeconomic status, but the adjustment for education, which is strongly associated with 
socioeconomic status, did not change the estimates. However, we cannot rule out that there are 
unknown confounders that have not been adjusted for. 
We compared a number of characteristics for participants who completed the questionnaire, both 
in the baseline study and the follow-up study, with those who only answered the questionnaire in 
the baseline study. Age and the education did not differ significantly between those who 
participated in the follow-up study and those who did not (drop-outs). The drop-outs had a slightly 
lower education. However, our main exposure sun exposure did not differ between those who 
participated and those who did not participate in the study. 
Overall limitation of this thesis is lack of data on nutrition in adolescence period thus it limits our 
conclusion of nutrition and its role across the entire lifespan. We explored a prenatal omega 3 
intake and children neurodevelopment and the Women Lifestyle and Health study provided me 
with a high quality data in order to explore the mental health outcomes in adulthood. Nevertheless 
the Swedish cohort allowed me to explore the sun exposure and vitamin D reports from as early 
as at age 10 which is also a critical period for an optimal brain development.  
Another shortcoming of the thesis is a lack of examination of a comprehensive set of outcomes. 
Other important outcomes such as cognitive functioning in adulthood, aging and other mental 














6.3 Integration of findings and comparisons with earlier research  
The results and conclusions of this thesis contribute to earlier research in several important ways.  
 
Fish Oil and Fish Intake during Pregnancy and Cognitive Functioning In Offspring: 
Systematic Review and Meta-Analysis of Randomised Control Trials and Observational 
Studies 
 
There has been considerable attention to the potential role of fish oil supplementation and oily 
fish intake during pregnancy and their link to the offspring’s cognitive abilities but with conflicting 
results. We summarised and integrated this information in a systematic way. In a Meta-Analysis 
we combined already published studies including both randomised control trials (supplementation 
with fish oil) and observational studies (fish intake during pregnancy). The randomized controlled 
trials showed better cognitive abilities in children of mothers in fish oil supplementation group. For 
the measure of overall cognitive ability the standardized difference in means (SMD) was 
estimated to 0.10 (95% CI, -0.01 to 0.20; p=0.07) and for memory functions the SMD was 0.21 
(95% CI, 0.01 to 0.41; p=0.04). The observational studies showed better overall cognitive ability 
with pooled OR of 1.92 (95% CI, 1.61 to 2.30; p<0.001) and for the domain of language and verbal 
skills the OR was 1.93 (95% CI, 1.37 to 2.73; p<0.001) among children of mothers consuming 2 
to 3 fish servings per week during pregnancy.  We evaluated cognition in a context of overall and 
specific cognitive abilities. The overall consistency of our findings, regardless of study type, is 
reassuring. 
Overall, one explanation for the heterogeneity of individual study results is that the discrepancies 
between observational studies and interventional studies might be due to the fact that omega-3 
PUFA in fish is more bioactive than fish oil in a form of supplementation. Also, socioeconomically 
advantaged pregnant women are more likely to have better balanced diet.  According to the 
previously published study, apart from omega-3 PUFA, fish consist of other beneficial nutrients 
(i.e. selenium, vitamin D, iodine) and these might play an important role in enhancement of 
cognition (Nesheim & Yaktine, 2007). Epidemiological studies are generally better powered but 
they might also potentially have less control for confounding. However, by integrating both 
designs we resolved the inconsistency of the findings and our Meta-Analysis confirmed the 
beneficial effect of prenatal omega 3 PUFA intake and this is in accordance with most 
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observational studies (Daniels et al., 2004; Oken et al., 2008). This thesis supports the large data 
published earlier from the Avon Longitudinal Study of Parents and Children (ALSPAC) in the UK 
regarding fish consumption and child cognitive development (Daniels et al., 2004; Hibbeln et al., 
2007). These studies found data that higher maternal fish consumption was associated with 
higher language (after appropriate adjustments) in 7421 British children assessed at 15 months, 
using the MacArthur Communicative Development Inventory (MCDI), and at 18 months using the 
Denver Developmental Screening test. The later ALSPAC study demonstrated that those children 
whose mothers consumed less seafood during pregnancy had lower IQ, measured by the 
Wechsler Intelligence Scale for Children III (WISC-III) at the age of 8 (after adjusting for a wide 
range of relevant covariates). Lower maternal seafood consumption was also linked to suboptimal 
language development (measured using the Denver Developmental Screening test) at six, 18, 
30, and 42 months of age in the same study (Hibbeln et al., 2007). 
Our results agree with what is expected following integration of the research and showing a 
stronger effect in epidemiological studies. In this up to date review and meta-analysis of all 
available literature, we found that prenatal fish oil was associated with better cognitive abilities in 
the offspring. We found concordance across reviewed study designs where randomised control 
trials supported the results of the observational studies. 
 
 
Sun Exposure, Vitamin D and Psychotic Experiences 
 
First we showed that compared with women who reported a history of one sunburn, the women 
with ‘None’ or ≥2 sunburn showed higher scores on the CAPE scale with more women in the right 
part of the distribution. Similarly, compared with women exposed to 1 week of sunbathing 
holidays, the women with none or ≥2 weeks showed higher scores on CAPE scale. The results 
were statistically significant across the entire distribution of the CAPE scale.  
 
The above results are novel as no study has previously considered an examination of UV 
exposure with relation to psychotic experiences in a general population. We observed a U-shape 




Figure 16  U-shaped relationship between different levels of sun exposure and psychotic like 
experiences. 
 
                        Low UV exposure               Moderate UV exposure                 High UV exposure 
 
 
Our results agree with the study published in JAMA that reported a similar U-shaped association 
examining risk for schizophrenia however the authors measured vitamin D levels in blood. They 
found that both low and high concentrations of neonatal vitamin D in Danish cohort are associated 
with increased risk of schizophrenia (J. J. McGrath, Eyles, et al., 2010).  
Our results are also in line with a longitudinal, nested case-control study in the Nordic countries 
reported a U-shape relationship between vitamin D levels and health outcomes. However, it was 
evaluated for a cancer risk not mental health outcomes. The study revealed that both high and 
low levels of blood vitamin D are associated with a higher prostate cancer risk (Tuohimaa et al., 
2004).  
This thesis and above mention studies that reported U-shaped associations between vitamin D 
and health outcomes (illustrated in figure 16) might be a potential indication for the fact that 
optimal levels of vitamin D and/or sun exposure are beneficial regardless of the health outcome. 
This non-linear association is evident especially in Nordic populations examining mental health 
 No psychotic experiences 
Psychotic experiences Psychotic experiences 
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outcomes.  However, the associations with dietary components and health are often non-linear 
with advantageous effects of a balanced nutrition. 
Concerning the impact of low vitamin D on the adolescent and adult brain and psychotic 
symptoms, a recent study based on a population-based birth cohort from South West England - 
ALSPAC, (n = 3,182), found an association between low vitamin D during childhood (mean age 
9 years) and an increased risk of psychotic symptoms during adolescence (mean age 14 years) 
(A. M. Tolppanen et al., 2012). A large population-based study of the same cohort of Swedish 
women as ours  (n = 33,623) found a significantly increased risk of psychotic experiences in those 
with low vitamin D intake from diet (Hedelin et al., 2010). Thus, our evidence enhances the 
knowledge that low sun exposure and low vitamin D not only disrupts early brain development 
but may also compromise later periods of brain growth and maturation and contribute to later 
mental health problems. 
 
The public health implications of our findings are ambiguous as long as the underlying mechanism 
is unclear. The highest UV exposure in our study were far below the exposures which would 
generally perceived as harmless, and we find it unlikely that the association between these higher 
sun exposures and increased psychotic experiences reflects a direct harmful effect of vitamin D. 
However, this study indicates that complex biological mechanisms are involved in the relationship 
between sun exposure, vitamin D and psychotic experiences in adult women, suggesting that 
recommendations of sun exposure in order to keep the optimal level of vitamin D should be 
considered with caution.   
This research does seem to show that there is a link between vitamin D form sun exposure and 
psychotic symptoms. However, we don’t know exactly what that link is. Research has not yet 
clearly shown whether low levels of vitamin D cause psychotic symptoms, or whether such 
symptoms cause low levels of vitamin D. This means that we are unsure whether taking a vitamin 
D supplement, or getting more vitamin D by exposing the skin to the sun, will help to prevent or 
ease the symptoms of psychotic symptoms or other mental health problems in some people.  
The adverse effects of UV radiation are easy to see but the beneficial effects are difficult to 
determine as they occur after many years, and might be influenced by other factors such as age, 
diet, smoking, etc. However, the health benefits are much stronger (Grant, 2009). 
Keeping in mind the review literature and the current study, there are a number of reasons why 
public health policies regarding UV irradiance and vitamin D are not where they should be. For 
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instance, the sunscreen industry proposed the idea that people should avoid the sun and apply 
the sunscreen before exposing to the sun. Consequently serum vitamin D concentrations have 
decreased globally (Grant, 2009). As mentioned in my introduction, moderate degree of UV 
exposure is necessary for the production of Vitamin D which is essential for physical and mental 
health. The findings from the present study provided additional evidence to support this-women 
with moderate sun exposure reported no psychotic experiences. Additionally, evidence emerges 
that low Vitamin D levels are likely to be associated with many chronic diseases. Considering a 
U-shaped association presented in this thesis and supported but other studies with vitamin D and 
mental, and physical health outcomes, public health policy on ultraviolet radiation needs to aim 
at preventing the disease burden associated both with excessive and with insufficient UV 
exposure. 
Further, our study used UV exposure as a main proxy for vitamin D levels as we believe this is 
the only valid source of vitamin D synthesis in humans. Because foods contain very little vitamin 
D it is difficult to obtain enough vitamin D from dietary sources even when consuming foods 
fortified with vitamin D. There has been a lot of discussion amongst researchers as to whether 
consumption of vitamin D from the diet or in a form of a supplement is the same as producing 
vitamin D3 in the skin when exposed to UVB. Because it takes approximately 8 h for previtamin 
D3 in the skin to fully convert to vitamin D3 and it takes additional time for the vitamin D3 to enter 
the dermal capillary bed this is at least 2 of the explanations for why it was observed that vitamin 
D3 produced in the skin last 2–3 times longer in the circulation when compared with oral 
consumption (Haddad, Matsuoka, Hollis, Hu, & Wortsman, 1993). Furthermore when vitamin D3 
is produced in the skin 100% of it is potentially bound to the vitamin D binding protein. When 
vitamin D3 is consumed in the diet or supplement it gets combined to chylomicrons which are 
transported into the lymphatic system and then into the venous system were approximately 60% 
of the vitamin D3 is bound to the vitamin D binding protein and 40% is rapidly cleared in the 









Note 10 D2=Vitamin D2 and D3=vitamin D3 
Note 11 Skin type II, III and IV 
 
The above figure 17 shows the importance of UVB exposure in vitamin D production. The figure 
presents a comparison of the percentage increase in serum 25(OH)D levels of healthy adults who 
were exposed to UVB radiation once a week for 3 months in a bathing suit of with healthy adults 
who received either 1000 IU of vitamin D2 or 1000 IU of vitamin D3 daily during the winter and 
early spring for a period of 11 weeks. The study showed that fifty percent increase represented 
approximately 10 ng/ml from baseline 18 ± 3 to 28 ± 4 ng/ml. in this study, skin type is based on 
the Fitzpatrick scale: Type II always burns, sometimes tans; type III always burns, always tans; 
type IV sometimes burns.  
 
 
It is possible that the accumulated exposure to sun over the life-course could result in brain 
alterations. Those with little or lack of sun exposure and those with the highest range of sun 
exposure reported psychotic experiences. Insufficiency of sun exposure produced less vitamin D 
resulting in more psychotic experiences. A similar pattern was observed for high sun exposure 
which could be a result of toxicity of vitamin D. However the literature on vitamin D states that 
hypercalcemia (toxicity due to high levels of vitamin D) is not a result of vitamin D from sun 
exposure or food but supplements only. Almost all vitamin D overdoses result from taking high 
amounts of vitamin D supplements. It is almost impossible to get too much vitamin D from sunlight 
or food. However, it can be speculated that overexposure to sun could break down vitamin D and 





Sun Exposure, Vitamin D and Depressive Symptoms 
 
Further investigation of sun exposure and mental health outcomes related to depressive 
symptoms in the Swedish cohort revealed that too much sun could result in occurrence of 
depressive symptoms in this particular sample of adult Swedish women. Women with multiple 
sunburns showed higher odd ratios for depressive symptoms. These results are partially 
comparable with the findings from the study above examining sun exposure and psychotic 
symptoms. It’s worth noting that in both these studies high exposure was associated with poorer 
mental health-reports of psychotic experiences and depressive symptoms. In the depression 
study, however, the association was evident only for multiple sunburns and not sunbathing 
holidays variable.   
Firstly, there is not a single study that examined the association between sun exposure and 
depressive symptoms in a general population. Secondly, the results from our study differ from 
previously published literature on vitamin D levels and depressive symptoms. For example, 
findings from one population based study supported a potential inverse association of vitamin D 
from food sources, and depressive symptoms in postmenopausal women (Bertone-Johnson et 
al., 2011). Contrary to the results of my study, findings from the ALSPAC study showed that higher 
concentrations of 25(OH)D3 assessed at mean age 9.8 years were associated with lower levels 
of depressive symptoms at age 13.8 years. A recent review by Anglin et al 2013 on vitamin D and 
depression looked at the all published good quality research studies that tested whether a lack of 
vitamin D in human’s blood is linked with being depressed or whether a lack of vitamin D in blood 
makes it more likely to develop depression (Anglin et al., 2013). These results were contrary to 
our findings on sun exposure and depressive symptoms indicating that there is a relationship 
between low levels of vitamin D in the blood and depression. A key message from an existing 
literature on vitamin D levels in blood and depression is that research does seem to show a link 
between low levels of vitamin D in the blood and symptoms of depression (Anglin et al., 2013; 
Berg et al., 2010; Jorde et al., 2008; Wilkins et al., 2006). Considering the results of our study on 
sun exposure as a proxy for vitamin D levels, the association is contradictory - the more sunburns 
the more depressive symptoms in the cohort of Swedish adult women.  
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From a behavioural point of view, several theories could be applied as potential explanation for 
the opposite association we found, one of them focused on self-medication theory explained 
earlier in chapter 5. In short, possible reasons for taking up too much sun could be related to self-
medication, the more sunshine the better health outcomes. Therefore women from the cohort 
could overexposed themselves to sun in order to improve their mood. Alternatively, women with 
more sunburns and depressive symptoms could exhibit patterns of high-risk behaviours, i.e. they 
have tendency to spend extra time in the sun until their skin burns.  There is a strong relationship 
between depression and high-risk behaviours.  
With current knowledge, biological explanation for this positive association between multiple 
sunburns and depressive symptoms is challenging. Some of the common symptoms of vitamin D 
overdose characterize depression. However, even for the women in our cohort who reported an 
overexposure to UV, it would be impossible to reach a toxic level of vitamin D. It is widely accepted 
that vitamin D produced in the skin as a result of sun exposure “is not known to result in toxic 
levels” (Blake, 2008). This is because levels produced in the skin are self-adjusting based on the 
body’s needs.  
However as far as we are aware, this is the first study showing a positive relationship between 
sun exposure and depressive symptoms and found no association between potential vitamin D 
deficiency and risk for later depressive symptoms. This does not rule out the fact that in already 
depressed cases there will be low levels of vitamin D and that vitamin D supplementation in 
depressed individuals will be effective. Moreover, it should be noted that the present study is a 
study of depressive symptoms and perhaps the association with symptoms is not the same as 
with the clinical conditions, this should be consider in other studies. As a comparable example, 
some studies show a link between psychotic symptoms and cognitive normalization in childhood 









6.4 Future directions 
 
This thesis presented the importance of nutrition (omega-3) in early neurodevelopment and later 
impact of nutrition (vitamin D measured by sun exposure behaviours) on mental health outcomes 
in adults (positive psychotic experiences and depressive symptoms). Although the aetiology of 
mental health is complex, the emerging and convincing indications for nutrients as an important 
factor for the high prevalence and incidence of frequent mental problems, such as depression or 
schizophrenia indicating that  balanced diet is as important in psychiatry as it is in other physical 
conditions such as cardiovascular disease or endocrinology. At the population level, we had 
scientific evidence that optimal sun exposure and vitamin D is associated with a lower incidence 
of positive psychotic symptoms and meta-analysis of RCTs and OS showed that prenatal omega-
3 especially DHA levels are associated with enhanced cognitive abilities.  
Firstly, focusing on omega 3, future studies should consider a recommended prenatal omega 3 
dosage and oily fish servings according to health governance recommendations to obtain any 
health benefit and enhance children cognitive abilities. At this stage it was difficult to conclude 
from the existing literature due to too many inconsistencies in prenatal dosage of omega 3. Also, 
a potential issue could be inconsistent measurements of children cognition. There is need for 
standardised assessments to adequately evaluate children cognitive development. This could 
also allow more reliable meta-analysis evaluation.  
Since animal studies have demonstrated that deprivation of omega-3 fatty acids during pregnancy 
is associated with behavioural deficits that cannot be reversed with postnatal supplementation 
(Coletta, Bell, & Roman, 2010), for these reasons, it is important for omega-3 fatty acids to be 
supplied to the fetus in adequate amounts throughout pregnancy. To optimize pregnancy 
outcomes and fetal health, consensus guidelines have recommended that pregnant women 
consume at least 200 mg of DHA per day. A woman can achieve this threshold by consuming 2 
to 3 servings of oily fish per week, dietary intake that is consistent with the current US Food and 
Drug Administration (FDA) and Environmental Protection Agency (EPA) advisory (Center for 
Food Safety and Applied Nutrition, 2014) 
In my research I have relied on the use of national registers which helped to get around several 
problems present in clinically based samples. However there is a lack of data connecting these 
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observations to the underlying biology. For this reason initiatives to enrich the register data with 
biological data would be valuable (vitamin D levels).  
Up to date, there is no a single cohort to answer all the questions. The main conclusion that I take 
away from this thesis is that research on vitamin D deficiency and its link to psychosis is at a very 
preliminary stage.  There is a need for more research in this area – particularly that addressing 
the potential use of vitamin D supplements therapeutically and the specificity of vitamin D 
deficiency to psychosis over other diagnoses. 
In this thesis the results of vitamin D from sun exposure and depressive symptoms analyses were 
somewhat contrary to previous studies. Further studies are needed to replicate these findings, 
preferably measuring blood levels of vitamin D in addition to sun exposure and there is a need 
for clinical trials including patients with clinical depression. 
It is difficult to expect that anyone affected with mental health problems would improve only with 
medicines. Anyone would argue that the forthcoming research in psychiatry requires a broader 
approach in which nutritional factors are vital to provide better functioning and quality of life.  
As stated by Cannel et al, “epidemiological evidence suggests that mental illness has increased 
as humans have migrated out of the sun and into buildings, cars, and sunblock” (Cannell et al., 
2006). 
We recommend for future prospective studies and randomized control trials to establish if the 
improvement of vitamin D status holds promise for the prevention of psychosis and/or depression, 
the treatment of it, or both.  
 
At present, there is still some evidence that does not support a role of vitamin D in adult mental 
health problems such as our study of vitamin D and depressive symptoms which makes vitamin 
D deficiency a more probable consequence than a cause of depression. Consequently, it’s 
acceptable to be sceptical for now as where research is available, it is limited and conflicting.  
What is needed is more involvement and more research pushing the development of this field 
further.  Other authors (D. W. Eyles, Burne, & McGrath, 2013) have outlined a feasible and 
persuasive argument for the role of vitamin D in the development of psychotic symptoms and  in 
accordance with the previous findings in this thesis we argue that, indeed, a similar conclusion 
could be drawn in the general population of adult Swedish women when under or over-exposed 
to the sun. However the vitamin D field in mental health research have been held back by the lack 
of well-designed studies. 
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Adjusted, standardized, pooled analyses would help clarify shape of vitamin D-psychotic 
symptoms association. Currently, the shape of the association from the published literature is 
variable for example, our study revealed a possible U-shaped relationship. There is an urgent 




To our knowledge, this is the first study of its kind to explore the association between nutrition 
and mental health in children and adults; however, we acknowledge that further studies that 
contribute to a stronger level of evidence are required. We recommend that the relationships 
between both poor nutrition and poorer mental health and good nutrition and better mental health 
be examined using longitudinal study designs.  
Prospective and intervention studies are now required to improve the level of evidence. Given 
that roughly half of all lifetime mental disorders in most studies start by the mid‐teens and three‐
fourths by the mid‐20s (Kessler et al., 2007). The potential for early intervention using strategies 
targeted at improving nutritional intake at a population level may be of substantial public health 
benefit.  
A good designed study to evaluate the relationship between nutrition (vitamin D and omega 3, for 
example) and development of mental health illness would be a prospective birth cohort with 
measurements of biological samples of vitamin D levels and micronutrients from diet at early age 
and assessment of psychotic and depressive experiences in early adolescence and adulthood. 
In the present study we were able to access data only for early developmental period and late 
adulthood. For example if psychotic and depressive symptoms are related to the development of 
schizophrenia or depression, this would support a possible protective association of higher 
vitamin D concentrations with schizophrenia and mood disorders. Further, as it is not possible to 
combine biological or dietary vitamin D intake and sun behaviour into a single exposure variable 
as their methods of assessment are very different, a suggestion for a well-designed future study 
is to collect biological measures and vitamin D from diet, and sun behaviour data in order to run 
adjusted analysis. If the results show a positive association, then it could be argued that the sun 
behaviour variables are associated with psychosis independently of dietary or biological vitamin 
D levels. Such a result would strengthen the conclusions of the present study as it would have 
shown that two or three separate ways of measuring vitamin D status have the same relationship.  
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Moreover, adding prescription data would be advantageous to further validate symptoms of 
interest (unfortunately this was not feasible for the present study considering my PhD time frame). 
Further, it would be of interest to study if nutrition such as omega 3 and vitamin D are associated 
with separable latent dimensions of positive psychotic symptoms or depression and if the 
associations are valid for men and for other age groups.  
Nevertheless, one attractive feature of the results of the present study is the potential for an 
intervention at the public health level. Programmes that aim to reduce the prevalence of omega 
3 insufficiency in pregnant women could translate into a lower incidence of cognitive impairments 
and possibly certain mental problems, such as schizophrenia, in their offspring. Just as folate 
supplementation has been shown to reduce the incidence of neural tube defects (Czeizel & 
Dudás, 1992), attention to certain nutrients (vitamin D status) could reduce the incidence of 
schizophrenia.  
Future studies should conduct a rigorous evaluation of the association between dietary behaviour 
across critical periods of development and cognitive functions and psychosis by looking at the 
nutrition intake prenatally through childhood and then adulthood. Up to date there is no a single 
cohort available to assess this. My thesis examined nutritional intake in pregnancy and child 
cognitive performance. It would be valuable to provide longitudinal data to examine the relation 
between children’ consumption of food rich in omega 3 in the years after birth and cognitive 
functioning and school performance, and mental health symptoms.. Thirdly, to examine further 
impact of nutrients on cognition and possible psychotic and depressive symptoms, it should be 
considered to look at the link between multiple nutrients and psychotic like symptoms in 
adulthood. The objective should be to look not only at omega 3 intakes but also to investigate 
multiple nutrients and the longitudinal relation between their consumption and psychotic and 
depressive symptoms in adults. In short, an ideal research project should provide a robust 
evidence for the ongoing debate on the role of nutrition through the lifespan as a possible risk 
factor for cognitive impairment and mental illness such as depression and psychosis. We 
attempted to examine this, however, considering lack of resources and PhD timelines, we lacked 
a complete evaluation of nutrients intake across lifespan as we only could access the data for 
prenatal nutrients (meta-analysis) and middle aged females (Swedish cohort). Also, to further 
strengthen an association between nutrients and mental health it would be valuable to assess 
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confounding by parental psychiatric history as well as information on psychiatric admissions from 
patients’ registry.  
 
Focusing on vitamin D, my results should motivate further longitudinal and experimental studies 
demonstrating consistent time-sequenced associations in order to further explore causality in the 
mental health-vitamin D link. Validating an involvement of vitamin D from sun exposure in the 
pathway to mental health problems such as psychosis and depression may have important 
implications. Although low levels of vitamin D are highly prevalent, potentially modifiable 
determinants of vitamin D status, such as dietary habits, use of dietary supplements and more 
importantly, behaviour related to sun exposure, could provide new selective cost-effective 
strategies aimed at preventing psychosis and/or depression, and their disease burden. Although 
there is much more work to be done, if future studies confirm the association between vitamin D 
deficiency and risk of mental health (schizophrenia or depression), it could increases the prospect 
of the primary prevention of mentioned mental problems in a comparable way to folate 
supplementation for the prevention of spina bifida (Czeizel & Dudás, 1992; Czeizel, Dudás, 
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Appendix C.  
SAS program for the quantile regression analysis 
 
*-- SAS formats ---------------------------------------------------; 
proc format; 
 
  value educcat 1='0-10yrs' 2='11-13yrs' 3='>13yrs'; 
  value bmifmt  1='=<25' 2='25-29.9' 3='=>30'; 
  value cun1fmt 0='Never' 1='1 week' 2='=2 weeks'; 
  value solbfmt 0='None' 1='1 time' 2='=2 time'; 
  VALUE NEWHOLS 0='Never' 1='=2 weeks' 2='1 week'; 
  VALUE NEWBURN 0='None' 1='=2 times'  2='1 time'; 
RUN;  




*-- Main program -----------------------------------------------------
--------; 
*Create plot of side by side bars for CAPE items; 
*-------------------------------------------------------------; 
data p1; 
  label cape='CAPE mean score'; 
  set study.wlh_cohort2; 
  keep lpnr cape f22_1 f22_2  f22_3 f22_4 f22_5 f22_6 f22_7 
                             f22_8 f22_9 f22_10 f22_11 f22_12 f22_13 
                             f22_14 f22_15 f22_16 f22_17 f22_18 f22_19 
f22_20; 
   
  
  *- Code 9 is a missing code; 
  if f22_1 > 7 then f22_1 = .m; 
  if f22_2 > 7 then f22_2 = .m; 
  if f22_3 > 7 then f22_3 = .m; 
  if f22_4 > 7 then f22_4 = .m; 
  if f22_5 > 7 then f22_5 = .m; 
  if f22_6 > 7 then f22_6 = .m; 
  if f22_7 > 7 then f22_7 = .m; 
  if f22_8 > 7 then f22_8 = .m; 
  if f22_9 > 7 then f22_9 = .m; 
  if f22_10 > 7 then f22_10 = .m; 
  if f22_11 > 7 then f22_11 = .m; 
  if f22_12 > 7 then f22_12 = .m; 
  if f22_13 > 7 then f22_13 = .m; 
  if f22_14 > 7 then f22_14 = .m; 
  if f22_15 > 7 then f22_15 = .m; 
  if f22_16 > 7 then f22_16 = .m; 
  if f22_17 > 7 then f22_17 = .m; 
  if f22_18 > 7 then f22_18 = .m; 
  if f22_19 > 7 then f22_19 = .m; 
  if f22_20 > 7 then f22_20 = .m; 






  SET study.wlh_cohort2; 








*-- Transpose the items so each variable is one row instead; 
proc sort data=p1;by lpnr;run; 
proc transpose data=p1 out=p2; 
  var f22_1 f22_2  f22_3 f22_4 f22_5 f22_6 f22_7 
      f22_8 f22_9 f22_10 f22_11 f22_12 f22_13 
      f22_14 f22_15 f22_16 f22_17 f22_18 f22_19 f22_20; 
  label f22_1='Double meaning' f22_2='Messages from TV' f22_3='False 
appearance' f22_4='Being persecuted' 
        f22_5='Conspiracy'     f22_6='Being important' f22_7=’Being 
special’ f22_8='Telepathy' f22_9='Influenced by devices' 
f22_10='Witchcraft, voodoo or the occult' 
        f22_11='Odd appearance' f22_12='Thought withdrawal' 
f22_13='Thought insertion' f22_14='Thought broadcasting' 
f22_15='Echoed thought' 
        f22_16='External control' f22_17='Verbal hallucinations' 
f22_18='Voices conversing' F22_19='Capgras syndrome' f22_20='Visual 
hallucinations'; 




*-- The item number is embedded in the variable names (now found in 
the _name_ variable); 
data p3; 
  attrib item length=4 label='The CAPE positive scale (items 1-20)'; 
  keep lpnr item col1 _label_; 
  set p2; 
  item=input(tranwrd(_name_, 'F22_', ''), 8.); 
run; 
 





filename hepp 'C:\WLH\sasproj\WLH\WLH1405\sasout\ordplt1.png'; 
 
goptions device=png xpixels=1240 ypixels=800 lfactor=1 
fontres=presentation 
         noborder cback=white htext=2 ftext="Thorndale AMT" htext=2 
hby=0 
         display gsfname=hepp gsfmode=replace rotate=L; 
 
 
%ssordplt(data=p3,  class=item, classlst=1 to 20 by 1, var=col1, 
ordinals=0 to 4 by 1, 
          ylabel=, bystmt=, width=0.15, sidepct=%str(3,3), force=0, 
zerolev=N, pattern=Y, 
          missing=Y, cut=4.5 9.5, 
          hsymbol=3, hangle=0, name=IVF, haxis=major=none); 
filename hepp clear; 
goptions reset=all; 
 
*-- Now print the unique labels describing each item. Use this as 
footnote; 
proc sql; 
  select distinct item, _label_ from p3 







*-- Create a dataset for the sunbathing holiday variable; 
data v2; 
  label cum_holiday='Cumulative sun exposure from sunbathing holidays 
at age 10-19 and 20-29'; 
  keep lpnr nsagest syden2 syden3 syden4 cum_holiday; 
  set study.nosve6; 
  format cum_holiday cun1fmt.;  
  if syden2 <= .z and syden3 <= .z then cum_holiday=.u; 
  else if syden2=0 and syden3=0 then cum_holiday=0;  
  else if (syden2 <=.z and syden3=0) or (syden2=0 and syden3 <=.z) 
then cum_holiday=0;  
  else if (syden2 <= .z and syden3=1) or (syden2=1 and syden3 <= .z) 
then cum_holiday=1; 
  else if syden2=1 and syden3=1 then cum_holiday=1; 
  else if (syden2=0 and syden3=1) or (syden2=1 and syden3=0) then 
cum_holiday=1; 




  label hols='Cumulative sun exposure from sunbathing holidays at all 
3 decades (age 10-19; 20-29 and 30-39)'; 
  keep lpnr nsagest syden2 syden3 syden4 hols ; 
  set work.v2; 
  format hols cun1fmt.;  
  if cum_holiday <= .z and syden4 <= .z then hols=.u; 
  else if cum_holiday=0 and syden4=0 then hols=0;  
  else if (cum_holiday <=.z and syden4=0) or (cum_holiday=0 and syden4 
<=.z) then hols=0;  
  else if (cum_holiday <= .z and syden4=1) or (cum_holiday=1 and 
syden4 <= .z) then hols=1; 
  else if cum_holiday=1 and syden4=1 then hols=1; 
  else if (cum_holiday=0 and syden4=1) or (cum_holiday=1 and syden4=0) 
then hols=1; 
  else hols=2; 
run; 
data hols10_19; 
  label hols10_19='Cumulative sun exposure from sunbathing holidays at 
age 10 to 19'; 
  keep lpnr nsagest syden2 hols10_19; 
  set study.nosve6; 
  format hols10_19 NEWHOLS.;  
  if syden2 <= .z  then hols10_19=.u; 
  else if syden2=0  then hols10_19=0;  
  else if syden2=1  then hols10_19=2; 
  else if syden2=> 2 then hols10_19=1; 
  else hols10_19= 1; 
   
run; 
data hols20_39; 
  label hols20_39 ='Cumulative sun exposure from history of sunburns 
at age 20 to 39'; 
  keep lpnr nsagest hols20_39; 
  set study.nosve6; 
  format hols20_39 NEWHOLS.;  
  if syden3 <= .z and syden4 <= .z then hols20_39=.u; 
  else if syden3=0 and syden4=0 then hols20_39=2;  
  else if (syden3 <=.z and syden4 =0) or (syden3=0 and syden4 <= .z) 
then hols20_39 =0;  
  else if (syden3 <= .z and syden4 =1) or (syden3=1 and syden4 <= .z) 
then hols20_39=2; 
  else if syden3=1 and syden4=1 then hols20_39=2; 
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  else if (syden3=0 and syden4=1) or (syden3=1 and syden4=0) then 
hols20_39=2; 




*-- Create a dataset for the sunburns variable; 
data v3; 
  label cum_sunburn='Cumulative number of annual sunburns at age 10 to 
29'; 
  keep lpnr nsagest solb2 solb3 solb4 cum_sunburn; 
  set study.nosve6; 
  format cum_sunburn solbfmt.; 
  if solb2 <= .z and solb3 <= .z then cum_sunburn=.u; 
  else if solb2=0 and solb3=0 then cum_sunburn=0;  
  else if (solb2 <=.z and solb3=0) or (solb2=0 and solb3 <=.z) then 
cum_sunburn=0;  
  else if (solb2 <= .z and solb3=1) or (solb2=1 and solb3 <= .z) then 
cum_sunburn=1; 
  else if solb2=1 and solb3=1 then cum_sunburn=1; 
  else if (solb2=0 and solb3=1) or (solb2=1 and solb3=0) then 
cum_sunburn=1; 
  else cum_sunburn=2; 
run; 
data sburn; 
  label sburn='Cumulative number of annual sunburns at age 10-19; 20-
29 and 30-39'; 
  keep lpnr nsagest solb2 solb3 solb4 cum_sunburn sburn; 
  set work.v3; 
  format sburn solbfmt.; 
  if cum_sunburn <= .z and solb4 <= .z then sburn=.u; 
  else if cum_sunburn=0 and solb4=0 then sburn=0;  
  else if (cum_sunburn <=.z and solb4=0) or (cum_sunburn=0 and solb4 
<=.z) then sburn=0;  
  else if (cum_sunburn <= .z and solb4=1) or (cum_sunburn=1 and solb4 
<= .z) then sburn=1; 
  else if cum_sunburn=1 and solb4=1 then sburn=1; 
  else if (cum_sunburn=0 and solb4=1) or (cum_sunburn=1 and solb4=0) 
then sburn=1; 




  label sburn10_19 ='Cumulative sun exposure from number of sunburns 
at age 10 to 19'; 
  keep lpnr nsagest sburn10_19; 
  set study.nosve6; 
  format sburn10_19 NEWBURN.;  
  if solb2 <= .z  then sburn10_19=.u; 
  else if solb2=0  then sburn10_19=0;  
  else if solb2=1  then sburn10_19=2; 
  else if solb2=> 2 then sburn10_19=1; 
  else sburn10_19= 1; 
   
run; 
data sburn20_39; 
  label sburn20_39 ='Cumulative sun exposure from number of sunburns 
at age 20 to 39'; 
  keep lpnr nsagest sburn20_39; 
  set study.nosve6; 
  format sburn20_39 NEWBURN.;  
  if solb3 <= .z and  solb4 <= .z then sburn20_39=.u; 
  else if solb3=0 and solb4=0 then sburn20_39=0;  
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  else if (solb3 <=.z and solb4=0) or (solb3=0 and solb4 <=.z) then 
sburn20_39 =0;  
  else if (solb3 <= .z and solb4=1) or (solb3=1 and solb4 <= .z) then 
sburn20_39=2; 
  else if solb3=1 and solb4=1 then sburn20_39=2; 
  else if (solb3=0 and solb4=1) or (solb3=1 and solb4=0) then 
sburn20_39=2; 
  else sburn20_39=1; 
run; 
   
 
DATA NEWREF; 
ATTRIB HOLS LENGTH=4 FORMAT=NEWHOLS. 
LABEL= 'WEEKS ON SUNBATHING HOLIDAYS'; 
SET HOLS; 
IF HOLS=0 THEN HOLS=0; 
ELSE IF HOLS=1 THEN HOLS=2; 





ATTRIB SBURN LENGTH=4 FORMAT=NEWBURN. 
LABEL= 'HISTORY OF SUNBURNS'; 
SET SBURN; 
IF SBURN=0 THEN SBURN=0; 
ELSE IF SBURN=1 THEN SBURN=2; 






*-- Create the combined sun exposure dataset; 
 
 
proc sort data=newref; by lpnr;run; 
proc sort data=newref2; by lpnr; run; 
proc sort data=hols10_19; by lpnr; run; 
proc sort data=sburn10_19; by lpnr; run; 
proc sort data=sburn20_39; by lpnr; run; 
proc sort data=hols20_39;by lpnr;run; 
 
data sunexp; 




*-- Create dataset for baseline subject characteristics; 
 
*--- Creating bmi categories: variable bmi from dataset nosve6---* ; 
data bmi; 
  keep lpnr nsagest BMI cbmi; 
  label cbmi='BMI categories'  nsagest='Age at baseline'; 
  format cbmi bmifmt.; 
  set study.nosve6; 
  if bmi <= .z then cbmi=.; 
  else if 0<=bmi< 25 then cbmi=1; 
  else if 25<=bmi<= 30 then cbmi=2; 
  else if 30<bmi then cbmi=3; 





*--- Creating categories for years in school: variable skole from 
dataset nosve6---* ; 
data skole; 
  label   skole='Years in education'  cskole='education categories'; 
  keep lpnr skole cskole; 
  format cskole educcat.; 
 
  set study.nosve6; 
 
  if skole<=.z then cskole= .; 
  else if skole=<10 then cskole= 1; 
  else if skole=<11 then cskole=2; 
  else if skole=<13 then cskole=3; 








* Creating a baseline dataset for analysis (without CAPE scores) to 
calculate missing values for baseline only; 
*-------------------------------------; 
 
proc sort data=sunexp;by lpnr;run; 
proc sort data=bmi; by lpnr; run; 
proc sort data=skole;by lpnr; run; 
data bsln(label='Baseline dataset'); 
  merge  sunexp bmi skole; 
  by lpnr; 
run; 
 
PROC SORT DATA=bsln; BY LPNR;RUN; 
PROC SORT DATA=p1; BY LPNR; RUN;  
proc sort data=cape_n; by lpnr;run; 
DATA analys1 (LABEL='ANALYSIS DATASET BASELINE+FU'); 
     MERGE bsln p1 cape_n; 




proc datasets lib=work mt=data nolist; 
     delete  p1  cape_n v1 v2 v3   sunexp skole  







*---Creating data set for follow up cohort in order to compare 




     set analys1; 
     if n= . then delete; 
run; 
*---excluding women with no answers to CAPE scale---*; 
data fu1; 
     set fu; 




*--- CAPE means for each CAPE variable (creating table with means for 
supplementary material)---*;  
 
DATA  analysismeans; 
   SET analys1 ; 
   label f22_1='Double meaning' f22_2='Messages from TV' f22_3='False 
appearance' f22_4='Being persecuted' 
        f22_5='Conspiracy'     f22_6='Being important' f22_7=’Being 
special’ f22_8='Telepathy' f22_9='Influenced by devices' 
f22_10='Witchcraft, voodoo or the occult' 
        f22_11='Odd appearance' f22_12='Thought withdrawal' 
f22_13='Thought insertion' f22_14='Thought broadcasting' 
f22_15='Echoed thought' 
        f22_16='External control' f22_17='Verbal hallucinations' 
f22_18='Voices conversing' F22_19='Capgras syndrome' f22_20='Visual 
hallucinations'; 
 keep F22_1-F22_20; 
RUN; 
 
PROC CONTENTS DATA=analysismeans; 
RUN; 
PROC MEANS DATA=analysismeans maxdec=1; 
RUN; 
 
title 'Demographic characteristics of the original cohort at baseline 
and follow up'; 
proc means data=bsln n nmiss mean std maxdec=2; 
 var skole nsagest; 
run;  
proc means data=fu1 n nmiss mean std maxdec=2; 




*--- Descriptive statistics: proc means ---*; 
 
title 'Descriptive statistics: proc means'; 
Proc means data=analys1 n nmiss mean std; 
 var skole nsagest; 
run; 






title1 'Mean and summary statistics by sun exposure levels (for Table 
1)'; 
proc means data=fu1 n nmiss mean std min max maxdec=1 nway; 
  var skole NSAGEST; 
  class hols; 
  run;  
proc means data=fu1 n nmiss mean std min max maxdec=1 nway; 
  var skole NSAGEST; 
  class sburn; 
  run;  
 proc means data=fu1 n nmiss mean min max maxdec=1; 
 var skole; 
 run; 
 
 proc freq data=fu1; 
 tables sburn; 
 run; 
 proc freq data=fu1; 
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 tables hols; 
 run; 







* Create plot of side by side bars for CAPE items ; 
*-------------------------------------------------------------; 
title 'M1: CAPE*sburn age education'; 
ods graphics on; 
ods output parameterestimates=pesburn; 
proc quantreg data=analys1 ORDER=INTERNAL outest=est1 ci=resampling 
algorithm=interior(tolerance=1.e-4); 
  class sburn; 




title 'M2: CAPE*hols age education';  
ods output parameterestimates=peshols; 
proc quantreg data=analys1 ORDER=INTERNAL outest=est1 ci=resampling 
algorithm=interior(tolerance=1.e-4); 
  class hols; 
  model cape = hols nsagest skole  / quantile= 0.10 to 0.90 by 0.10 




*-- Select only main exposures to plot and sort the data; 
proc sort data=pesburn out=pesburn1; 
  where parameter='SBURN' and df>0; 
  by parameter level1 quantile; 
run; 
proc sort data=peshols out=peshols1; 
  where parameter='HOLS' and df>0; 
  by parameter level1 quantile; 
run; 
 
*-- Combine all results so they can be plotted together; 
data pesburn2; 
  attrib estimate label='PEs Change vs 1 time' line length=$20 
         sglegend length=$30 level1 label='Number of times' 
         quantile label='Quantile' 
  ; 
 
  set pesburn1(in=sburn) peshols1(in=hols); 
 
  if hols then sglegend='Sunbathing holidays'; 
  else if sburn then sglegend='History of Sunburns'; 
  else abort; 
 
  if level1='1 time' then line='SOLID '; 
  else if level1='1 week' then line='SOLID '; 










ods graphics / reset=index imagename="sun_quantplot_1" 
               width=14cm height=14cm antialias 
               noborder; 
 
title;footnote; 
proc sgpanel data=pesburn2; 
  panelby sglegend / columns=1 rows=2 novarname; 
 
  band   x=quantile lower=lowercl upper=uppercl / transparency=0.7 
group=level1; 
  series x=quantile y=estimate / group=level1 group=line 
lineattrs=(color='black' thickness=1); 
 
  refline 0 / axis=y; 
  colaxis values=(0.2 to 0.9 by 0.1); 
  rowaxis min=-0.02 max=0.04 label='Change in CAPE scale ("1 





Appendix D.  
SAS program/Sensitivity Analysis for the sun exposure and 
psychotic symptoms study  
*---SUBGROUP ANALYSES---*; 
*---Cumulative sun exposure and CAPE scores over childhood and early 
adulthood age 10-19 years---*; 
*-------------------------------------------------------------; 
 
title 'Exposure at childhood sunbathing holidays at age 10-19, 
hols10_19'; 
ods graphics on; 
ods output parameterestimates=peshols; 
proc quantreg data=analys1 ORDER=INTERNAL outest=est1 ci=resampling 
algorithm=interior(tolerance=1.e-4); 
  class hols10_19; 
  model cape = hols10_19 nsagest skole  / quantile= 0.10 to 0.90 by 
0.10 plot=quantplot(hols10_19) seed=12345; 
run; 
 
title 'Exposure at age 10-19,  sburn10_19';  
ods output parameterestimates=pesburn; 
proc quantreg data=analys1 ORDER=INTERNAL outest=est1 ci=resampling 
algorithm=interior(tolerance=1.e-4); 
  class sburn10_19; 
  model cape = sburn10_19 nsagest skole  / quantile= 0.10 to 0.90 by 




*-- Select only main exposures to plot and sort the data; 
proc sort data=pesburn out=pesburn1; 
  where parameter='sburn10_19' and df>0; 




proc sort data=peshols out=peshols1; 
  where parameter='hols10_19' and df>0; 
  by parameter level1 quantile; 
run; 
 
*-- Combine all results so they can be plotted together; 
data pesburn2; 
  attrib estimate label='PEs Change vs 1 time age 10-19' line 
length=$20 
         sglegend length=$30 level1 label='Number of times' 
         quantile label='Quantile' 
  ; 
 
  set pesburn1(in=sburn10_19) peshols1(in=hols10_19); 
 
  if hols10_19 then sglegend='Sunbathing holidays'; 
  else if sburn10_19 then sglegend='History of Sunburns'; 
  else abort; 
 
  if level1='1 time' then line='SOLID '; 
  else if level1='1 week' then line='SOLID '; 





ods listing  gpath= 'C:\WLH\sasproj\WLH\WLH1405\saspgm' image_dpi=300 
; 
 
ods graphics / reset=index imagename="sun10_19_quantplot_1" 
               width=14cm height=14cm antialias 
               noborder; 
 
title;footnote; 
proc sgpanel data=pesburn2; 
  panelby sglegend / columns=1 rows=2 novarname; 
 
  band   x=quantile lower=lowercl upper=uppercl / transparency=0.7 
group=level1; 
  series x=quantile y=estimate / group=level1 group=line 
lineattrs=(color='black' thickness=1); 
 
  refline 0 / axis=y; 
  colaxis values=(0.2 to 0.9 by 0.1); 
  rowaxis min=-0.02 max=0.04 label='Change in CAPE scale age 10-19 ("1 




*---Cumulative sun exp and cape scores over adulthood (20_39 years)---
*; 
title 'Exposure at  age hols20_39'; 
ods graphics on; 
ods output parameterestimates=pesholsadult; 
proc quantreg data=analys1 ORDER=INTERNAL outest=est1 ci=resampling 
algorithm=interior(tolerance=1.e-4); 
  class hols20_39; 
  model cape = hols20_39 nsagest skole  / quantile= 0.10 to 0.90 by 
0.10 plot=quantplot(hols20_39) seed=12345; 
run; 
 
title 'Exposure at age sburn20_39';  
ods output parameterestimates=pesburnadult; 
140 
 
proc quantreg data=analys1 ORDER=INTERNAL outest=est1 ci=resampling 
algorithm=interior(tolerance=1.e-4); 
  class sburn20_39; 
  model cape = sburn20_39 nsagest skole  / quantile= 0.10 to 0.90 by 




*-- Select only main exposures to plot and sort the data; 
proc sort data=pesburnadult out=pesburnadult1; 
  where parameter='sburn20_39' and df>0; 
  by parameter level1 quantile; 
run; 
proc sort data=pesholsadult out=pesholsadult1; 
  where parameter='hols20_39' and df>0; 
  by parameter level1 quantile; 
run; 
 
*-- Combine all results so they can be plotted together; 
data pesburnadult2; 
  attrib estimate label='PEs Change vs 1 time age 20-39' line 
length=$20 
         sglegend length=$30 level1 label='Number of times' 
         quantile label='Quantile' 
  ; 
 
  set pesburnadult1(in=sburn20_39) pesholsadult1(in=hols20_39); 
 
  if hols20_39 then sglegend='Sunbathing holidays'; 
  else if sburn20_39 then sglegend='History of Sunburns'; 
  else abort; 
 
  if level1='1 time' then line='SOLID '; 
  else if level1='1 week' then line='SOLID '; 





ods listing  gpath= 'C:\WLH\sasproj\WLH\WLH1405\saspgm' image_dpi=300 
; 
 
ods graphics / reset=index imagename="sun20_39_quantplot_1" 
               width=14cm height=14cm antialias 
               noborder; 
 
title;footnote; 
proc sgpanel data=pesburnadult2; 
  panelby sglegend / columns=1 rows=2 novarname; 
 
  band   x=quantile lower=lowercl upper=uppercl / transparency=0.7 
group=level1; 
  series x=quantile y=estimate / group=level1 group=line 
lineattrs=(color='black' thickness=1); 
 
  refline 0 / axis=y; 
  colaxis values=(0.2 to 0.9 by 0.1); 
  rowaxis min=-0.02 max=0.04 label='Change in CAPE scale age 20-39 ("1 
time/week" as comparison group)'; 
run; 
 






*---HOST CHARACTERISTICS RELATED TO UV SENSITIVITY:X_SOLLENGE, 
SOLSTART, HARFARGE, OYEFARGE, 
SSKREM AND CAPE SCORES---*; 
 
data sensitive; 














proc sort data=sensitive; by lpnr;run; 
proc sort data=sensitive2; by lpnr; run; 
proc sort data=skin; by lpnr; run; 
data skintype; 





proc datasets lib=work mt=data nolist; 
  delete  sensitive skin sensitive2 ; 





title 'HOST CHARACTERISTICS RELATED TO UV SENSITIVITY:solstart'; 
ods pdf; 
ods graphics on; 
proc quantreg ci=resampling ORDER=INTERNAL 
algorithm=interior(tolerance=1.e-4) 
              data=skintype ; 
 
      class hols; 
      model cape = hols nsagest skole solstart /  
                   quantile=0.05,0.1 to 0.9 by 0.1,0.95 
                   seed=1234567 
                   plot=quantplot; 
   run; 
     




ods graphics on; 
proc quantreg ci=resampling ORDER=INTERNAL 
algorithm=interior(tolerance=1.e-4) 
                 data=skintype ; 
 
      class sburn; 
      model cape = sburn nsagest skole solstart /  
                   quantile=0.05,0.1 to 0.9 by 0.1,0.95 
                   seed=1234567 
                   plot=quantplot; 
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   run; 
     









  length ind 3; 
  set analys1 (keep=lpnr nsagest cbmi skole  hols sburn cape); 
  if cape = . then ind=1; else ind=0; 
run; 
 
proc logistic data=dropouts; 
  class cbmi  hols sburn hols; 
  model ind(event='1') = cbmi skole hols sburn hols ; 




*--Create the IPW weights; 
data dropouts1; 
  keep lpnr ipw; 
  set t3; 
  IPW = 1/ps_pred; 
  if ipw > .z ; 
run; 
 
*--  distribution of weights; 





*-- Join in the weights to the analysis dataset; 
proc sql; 
  create table dropouts1 as 
  select a.*, b.ipw 
  from dropouts as a 
  left join dropouts1 as b 
  on a.lpnr=b.lpnr 




*-- Apply the weights; 
ods graphics on; 
ods output parameterestimates=pesburn; 
proc quantreg data=dropouts1 ORDER=INTERNAL outest=est1 ci=resampling 
algorithm=interior(tolerance=1.e-4); 
  class sburn; 
  model cape = sburn nsagest skole / quantile= 0.10 to 0.90 by 0.10 
plot=quantplot(sburn) seed=12345; 
                   
run; 
 
ods output parameterestimates=peshols; 
proc quantreg data=dropouts1 ORDER=INTERNAL outest=est1 ci=resampling 
algorithm=interior(tolerance=1.e-4); 
  class hols; 
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  model cape = hols nsagest skole / quantile= 0.10 to 0.90 by 0.10 
plot=quantplot(sburn) seed=12345; 
                    
run; 
 
*-- Select only main exposures to plot and sort the data; 
proc sort data=pesburn out=pesburn1; 
  where parameter='SBURN' and df>0; 
  by parameter level1 quantile; 
run; 
proc sort data=peshols out=peshols1; 
  where parameter='HOLS' and df>0; 
  by parameter level1 quantile; 
run; 
 
*-- Combine all results so they can be plotted together; 
data pesburn2; 
  attrib estimate label='PEs Change vs 1 time' line length=$20 
         sglegend length=$30 level1 label='Number of times' 
         quantile label='Quantile' 
  ; 
 
  set pesburn1(in=sburn) peshols1(in=hols); 
 
  if hols then sglegend='Sunbathing holidays'; 
  else if sburn then sglegend='History of Sunburns'; 
  else abort; 
 
  if level1='1 time' then line='SOLID '; 
  else if level1='1 week' then line='SOLID '; 









ods listing  gpath= 'C:\WLH\sasproj\WLH\WLH1405\saspgm' image_dpi=300 
; 
 
ods graphics / reset=index imagename="sunwights_quantplot_1" 
               width=14cm height=14cm antialias 
               noborder; 
 
title;footnote; 
proc sgpanel data=pesburn2; 
  panelby sglegend / columns=1 rows=2 novarname; 
 
  band   x=quantile lower=lowercl upper=uppercl / transparency=0.7 
group=level1; 
  series x=quantile y=estimate / group=level1 group=line 
lineattrs=(color='black' thickness=1); 
 
  refline 0 / axis=y; 
  colaxis values=(0.2 to 0.9 by 0.1); 
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